#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Fronto-striatal effective connectivity of working memory in adults with cannabis use disorder Previous working memory (WM) studies found that relative to controls, subjects with cannabis use disorder (CUD) showed greater brain activation in some regions (e.g., left [L] and right [R] ventrolateral prefrontal cortex [VLPFC], and L dorsolateral prefrontal cortex [L-DLPFC]), and lower activation in other regions (e.g., R-DLPFC).
1-1	0-15	Fronto-striatal	_
1-2	16-25	effective	_
1-3	26-38	connectivity	_
1-4	39-41	of	_
1-5	42-49	working	_
1-6	50-56	memory	_
1-7	57-59	in	_
1-8	60-66	adults	http://maven.renci.org/NeuroBridge/neurobridge#SubjectwithoutDisorder
1-9	67-71	with	http://maven.renci.org/NeuroBridge/neurobridge#SubjectwithoutDisorder
1-10	72-80	cannabis	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse
1-11	81-84	use	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse
1-12	85-93	disorder	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse
1-13	94-102	Previous	_
1-14	103-110	working	_
1-15	111-117	memory	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
1-16	118-119	(	_
1-17	120-122	WM	_
1-18	123-124	)	_
1-19	125-132	studies	_
1-20	133-138	found	_
1-21	139-143	that	_
1-22	144-152	relative	_
1-23	153-155	to	_
1-24	156-164	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
1-25	165-166	,	_
1-26	167-175	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
1-27	176-180	with	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
1-28	181-189	cannabis	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse
1-29	190-193	use	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse
1-30	194-202	disorder	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse
1-31	203-204	(	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse
1-32	205-208	CUD	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse
1-33	209-210	)	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse
1-34	211-217	showed	_
1-35	218-225	greater	_
1-36	226-231	brain	_
1-37	232-242	activation	_
1-38	243-245	in	_
1-39	246-250	some	_
1-40	251-258	regions	_
1-41	259-260	(	_
1-42	261-265	e.g.	_
1-43	266-267	,	_
1-44	268-272	left	_
1-45	273-274	[	_
1-46	275-276	L	_
1-47	277-278	]	_
1-48	279-282	and	_
1-49	283-288	right	_
1-50	289-290	[	_
1-51	291-292	R	_
1-52	293-294	]	_
1-53	295-308	ventrolateral	_
1-54	309-319	prefrontal	_
1-55	320-326	cortex	_
1-56	327-328	[	_
1-57	329-334	VLPFC	_
1-58	335-336	]	_
1-59	337-338	,	_
1-60	339-342	and	_
1-61	343-344	L	_
1-62	345-357	dorsolateral	_
1-63	358-368	prefrontal	_
1-64	369-375	cortex	_
1-65	376-377	[	_
1-66	378-385	L-DLPFC	_
1-67	386-387	]	_
1-68	388-389	)	_
1-69	390-391	,	_
1-70	392-395	and	_
1-71	396-401	lower	_
1-72	402-412	activation	_
1-73	413-415	in	_
1-74	416-421	other	_
1-75	422-429	regions	_
1-76	430-431	(	_
1-77	432-436	e.g.	_
1-78	437-438	,	_
1-79	439-446	R-DLPFC	_
1-80	447-448	)	_
1-81	449-450	.	_

Text=In this study, effective connectivity (EC) analysis was applied to functional magnetic resonance imaging data acquired from 23 CUD subjects and 23 controls (two groups matched for sociodemographic factors and substance use history) while performing an n-back WM task with interleaved 2-back and 0-back periods.
2-1	451-453	In	_
2-2	454-458	this	_
2-3	459-464	study	_
2-4	465-466	,	_
2-5	467-476	effective	_
2-6	477-489	connectivity	_
2-7	490-491	(	_
2-8	492-494	EC	_
2-9	495-496	)	_
2-10	497-505	analysis	_
2-11	506-509	was	_
2-12	510-517	applied	_
2-13	518-520	to	_
2-14	521-531	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-15	532-540	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-16	541-550	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-17	551-558	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-18	559-563	data	_
2-19	564-572	acquired	_
2-20	573-577	from	_
2-21	578-580	23	_
2-22	581-584	CUD	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
2-23	585-593	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
2-24	594-597	and	_
2-25	598-600	23	_
2-26	601-609	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
2-27	610-611	(	_
2-28	612-615	two	_
2-29	616-622	groups	_
2-30	623-630	matched	_
2-31	631-634	for	_
2-32	635-651	sociodemographic	_
2-33	652-659	factors	_
2-34	660-663	and	_
2-35	664-673	substance	_
2-36	674-677	use	_
2-37	678-685	history	_
2-38	686-687	)	_
2-39	688-693	while	_
2-40	694-704	performing	_
2-41	705-707	an	_
2-42	708-714	n-back	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
2-43	715-717	WM	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
2-44	718-722	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
2-45	723-727	with	_
2-46	728-739	interleaved	_
2-47	740-746	2-back	_
2-48	747-750	and	_
2-49	751-757	0-back	_
2-50	758-765	periods	_
2-51	766-767	.	_

Text=A 2-back minus 0-back modulator was defined to measure the modulatory changes of EC corresponding to the 2-back relative to 0-back conditions.
3-1	768-769	A	_
3-2	770-776	2-back	_
3-3	777-782	minus	_
3-4	783-789	0-back	_
3-5	790-799	modulator	_
3-6	800-803	was	_
3-7	804-811	defined	_
3-8	812-814	to	_
3-9	815-822	measure	_
3-10	823-826	the	_
3-11	827-837	modulatory	_
3-12	838-845	changes	_
3-13	846-848	of	_
3-14	849-851	EC	_
3-15	852-865	corresponding	_
3-16	866-868	to	_
3-17	869-872	the	_
3-18	873-879	2-back	_
3-19	880-888	relative	_
3-20	889-891	to	_
3-21	892-898	0-back	_
3-22	899-909	conditions	_
3-23	910-911	.	_

Text=Compared to the controls, the CUD group showed smaller modulatory change in the R-DLPFC to L-caudate pathway, and greater modulatory changes in L-DLPFC to L-caudate, R-DLPFC to R- caudate, and R-VLPFC to L-caudate pathways.
4-1	912-920	Compared	_
4-2	921-923	to	_
4-3	924-927	the	_
4-4	928-936	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-5	937-938	,	_
4-6	939-942	the	_
4-7	943-946	CUD	_
4-8	947-952	group	_
4-9	953-959	showed	_
4-10	960-967	smaller	_
4-11	968-978	modulatory	_
4-12	979-985	change	_
4-13	986-988	in	_
4-14	989-992	the	_
4-15	993-1000	R-DLPFC	_
4-16	1001-1003	to	_
4-17	1004-1013	L-caudate	_
4-18	1014-1021	pathway	_
4-19	1022-1023	,	_
4-20	1024-1027	and	_
4-21	1028-1035	greater	_
4-22	1036-1046	modulatory	_
4-23	1047-1054	changes	_
4-24	1055-1057	in	_
4-25	1058-1065	L-DLPFC	_
4-26	1066-1068	to	_
4-27	1069-1078	L-caudate	_
4-28	1079-1080	,	_
4-29	1081-1088	R-DLPFC	_
4-30	1089-1091	to	_
4-31	1092-1094	R-	_
4-32	1095-1102	caudate	_
4-33	1103-1104	,	_
4-34	1105-1108	and	_
4-35	1109-1116	R-VLPFC	_
4-36	1117-1119	to	_
4-37	1120-1129	L-caudate	_
4-38	1130-1138	pathways	_
4-39	1139-1140	.	_

Text=Based on previous fMRI studies consistently suggesting that greater brain activations are related to a compensatory mechanism for cannabis neural effects (less regional brain activations), the smaller modulatory change in the R-DLPFC to L-caudate EC may be compensated by the larger modulatory changes in the other prefrontal-striatal ECs in the CUD individuals.
5-1	1141-1146	Based	_
5-2	1147-1149	on	_
5-3	1150-1158	previous	_
5-4	1159-1163	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-5	1164-1171	studies	_
5-6	1172-1184	consistently	_
5-7	1185-1195	suggesting	_
5-8	1196-1200	that	_
5-9	1201-1208	greater	_
5-10	1209-1214	brain	_
5-11	1215-1226	activations	_
5-12	1227-1230	are	_
5-13	1231-1238	related	_
5-14	1239-1241	to	_
5-15	1242-1243	a	_
5-16	1244-1256	compensatory	_
5-17	1257-1266	mechanism	_
5-18	1267-1270	for	_
5-19	1271-1279	cannabis	_
5-20	1280-1286	neural	_
5-21	1287-1294	effects	_
5-22	1295-1296	(	_
5-23	1297-1301	less	_
5-24	1302-1310	regional	_
5-25	1311-1316	brain	_
5-26	1317-1328	activations	_
5-27	1329-1330	)	_
5-28	1331-1332	,	_
5-29	1333-1336	the	_
5-30	1337-1344	smaller	_
5-31	1345-1355	modulatory	_
5-32	1356-1362	change	_
5-33	1363-1365	in	_
5-34	1366-1369	the	_
5-35	1370-1377	R-DLPFC	_
5-36	1378-1380	to	_
5-37	1381-1390	L-caudate	_
5-38	1391-1393	EC	_
5-39	1394-1397	may	_
5-40	1398-1400	be	_
5-41	1401-1412	compensated	_
5-42	1413-1415	by	_
5-43	1416-1419	the	_
5-44	1420-1426	larger	_
5-45	1427-1437	modulatory	_
5-46	1438-1445	changes	_
5-47	1446-1448	in	_
5-48	1449-1452	the	_
5-49	1453-1458	other	_
5-50	1459-1478	prefrontal-striatal	_
5-51	1479-1482	ECs	_
5-52	1483-1485	in	_
5-53	1486-1489	the	_
5-54	1490-1493	CUD	_
5-55	1494-1505	individuals	_
5-56	1506-1507	.	_

Text=Methods and materials Participants Data were obtained from the Human Connectome Project (HCP).
6-1	1508-1515	Methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
6-2	1516-1519	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
6-3	1520-1529	materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
6-4	1530-1542	Participants	_
6-5	1543-1547	Data	_
6-6	1548-1552	were	_
6-7	1553-1561	obtained	_
6-8	1562-1566	from	_
6-9	1567-1570	the	_
6-10	1571-1576	Human	_
6-11	1577-1587	Connectome	_
6-12	1588-1595	Project	_
6-13	1596-1597	(	_
6-14	1598-1601	HCP	_
6-15	1602-1603	)	_
6-16	1604-1605	.	_

Text=The experiments were performed in accordance with relevant guidelines and regulations and all experimental protocol was approved by the Institutional Review Board (IRB) (IRB #201204036; Title: ‘ Mapping the Human Connectome: Structure, Function, and Heritability ’).
7-1	1606-1609	The	_
7-2	1610-1621	experiments	_
7-3	1622-1626	were	_
7-4	1627-1636	performed	_
7-5	1637-1639	in	_
7-6	1640-1650	accordance	_
7-7	1651-1655	with	_
7-8	1656-1664	relevant	_
7-9	1665-1675	guidelines	_
7-10	1676-1679	and	_
7-11	1680-1691	regulations	_
7-12	1692-1695	and	_
7-13	1696-1699	all	_
7-14	1700-1712	experimental	_
7-15	1713-1721	protocol	_
7-16	1722-1725	was	_
7-17	1726-1734	approved	_
7-18	1735-1737	by	_
7-19	1738-1741	the	_
7-20	1742-1755	Institutional	_
7-21	1756-1762	Review	_
7-22	1763-1768	Board	_
7-23	1769-1770	(	_
7-24	1771-1774	IRB	_
7-25	1775-1776	)	_
7-26	1777-1778	(	_
7-27	1779-1782	IRB	_
7-28	1783-1784	#	_
7-29	1785-1794	201204036	_
7-30	1795-1796	;	_
7-31	1797-1802	Title	_
7-32	1803-1804	:	_
7-33	1805-1806	‘	_
7-34	1807-1814	Mapping	_
7-35	1815-1818	the	_
7-36	1819-1824	Human	_
7-37	1825-1835	Connectome	_
7-38	1836-1837	:	_
7-39	1838-1847	Structure	_
7-40	1848-1849	,	_
7-41	1850-1858	Function	_
7-42	1859-1860	,	_
7-43	1861-1864	and	_
7-44	1865-1877	Heritability	_
7-45	1878-1879	’	_
7-46	1880-1881	)	_
7-47	1882-1883	.	_

Text=Written informed consent was obtained from all participants.
8-1	1884-1891	Written	_
8-2	1892-1900	informed	_
8-3	1901-1908	consent	_
8-4	1909-1912	was	_
8-5	1913-1921	obtained	_
8-6	1922-1926	from	_
8-7	1927-1930	all	_
8-8	1931-1943	participants	_
8-9	1944-1945	.	_

Text=Our data analysis was performed in accordance with ethical guidelines of the Virginia Commonwealth University.
9-1	1946-1949	Our	_
9-2	1950-1954	data	_
9-3	1955-1963	analysis	_
9-4	1964-1967	was	_
9-5	1968-1977	performed	_
9-6	1978-1980	in	_
9-7	1981-1991	accordance	_
9-8	1992-1996	with	_
9-9	1997-2004	ethical	_
9-10	2005-2015	guidelines	_
9-11	2016-2018	of	_
9-12	2019-2022	the	_
9-13	2023-2031	Virginia	_
9-14	2032-2044	Commonwealth	_
9-15	2045-2055	University	_
9-16	2056-2057	.	_

Text=The subject inclusion criteria were: (I) right-handed; (II) lifetime cannabis dependence (for CUD subjects) as defined by the Self-Reported Substance Use and Abuse measures from Semi-Structured Assessment for the Genetics of Alcoholism; and (III) positive urine test for delta-9-tetrahydrocannabinol (THC) (for CUD subjects).
10-1	2058-2061	The	_
10-2	2062-2069	subject	_
10-3	2070-2079	inclusion	_
10-4	2080-2088	criteria	_
10-5	2089-2093	were	_
10-6	2094-2095	:	_
10-7	2096-2097	(	_
10-8	2098-2099	I	_
10-9	2100-2101	)	_
10-10	2102-2114	right-handed	_
10-11	2115-2116	;	_
10-12	2117-2118	(	_
10-13	2119-2121	II	_
10-14	2122-2123	)	_
10-15	2124-2132	lifetime	_
10-16	2133-2141	cannabis	_
10-17	2142-2152	dependence	_
10-18	2153-2154	(	_
10-19	2155-2158	for	_
10-20	2159-2162	CUD	_
10-21	2163-2171	subjects	_
10-22	2172-2173	)	_
10-23	2174-2176	as	_
10-24	2177-2184	defined	_
10-25	2185-2187	by	_
10-26	2188-2191	the	_
10-27	2192-2205	Self-Reported	_
10-28	2206-2215	Substance	_
10-29	2216-2219	Use	_
10-30	2220-2223	and	_
10-31	2224-2229	Abuse	_
10-32	2230-2238	measures	_
10-33	2239-2243	from	_
10-34	2244-2259	Semi-Structured	_
10-35	2260-2270	Assessment	_
10-36	2271-2274	for	_
10-37	2275-2278	the	_
10-38	2279-2287	Genetics	_
10-39	2288-2290	of	_
10-40	2291-2301	Alcoholism	_
10-41	2302-2303	;	_
10-42	2304-2307	and	_
10-43	2308-2309	(	_
10-44	2310-2313	III	_
10-45	2314-2315	)	_
10-46	2316-2324	positive	_
10-47	2325-2330	urine	_
10-48	2331-2335	test	_
10-49	2336-2339	for	_
10-50	2340-2368	delta-9-tetrahydrocannabinol	_
10-51	2369-2370	(	_
10-52	2371-2374	THC	_
10-53	2375-2376	)	_
10-54	2377-2378	(	_
10-55	2379-2382	for	_
10-56	2383-2386	CUD	_
10-57	2387-2395	subjects	_
10-58	2396-2397	)	_
10-59	2398-2399	.	_

Text=The positive THC result and other drug use measures are based on the data and HCP Data Dictionary released by HCP (https: //db.humanconnectome.org/data/projects/HCP_1200.
11-1	2400-2403	The	_
11-2	2404-2412	positive	_
11-3	2413-2416	THC	_
11-4	2417-2423	result	_
11-5	2424-2427	and	_
11-6	2428-2433	other	_
11-7	2434-2438	drug	_
11-8	2439-2442	use	_
11-9	2443-2451	measures	_
11-10	2452-2455	are	_
11-11	2456-2461	based	_
11-12	2462-2464	on	_
11-13	2465-2468	the	_
11-14	2469-2473	data	_
11-15	2474-2477	and	_
11-16	2478-2481	HCP	_
11-17	2482-2486	Data	_
11-18	2487-2497	Dictionary	_
11-19	2498-2506	released	_
11-20	2507-2509	by	_
11-21	2510-2513	HCP	_
11-22	2514-2515	(	_
11-23	2516-2521	https	_
11-24	2522-2523	:	_
11-25	2524-2571	//db.humanconnectome.org/data/projects/HCP_1200	_
11-26	2572-2573	.	_

Text=Information regarding the device and THC threshold used for the urine test is not directly available to the authors of this manuscript.
12-1	2574-2585	Information	_
12-2	2586-2595	regarding	_
12-3	2596-2599	the	_
12-4	2600-2606	device	_
12-5	2607-2610	and	_
12-6	2611-2614	THC	_
12-7	2615-2624	threshold	_
12-8	2625-2629	used	_
12-9	2630-2633	for	_
12-10	2634-2637	the	_
12-11	2638-2643	urine	_
12-12	2644-2648	test	_
12-13	2649-2651	is	_
12-14	2652-2655	not	_
12-15	2656-2664	directly	_
12-16	2665-2674	available	_
12-17	2675-2677	to	_
12-18	2678-2681	the	_
12-19	2682-2689	authors	_
12-20	2690-2692	of	_
12-21	2693-2697	this	_
12-22	2698-2708	manuscript	_
12-23	2709-2710	.	_

Text=The exclusion criteria were: (I) higher than moderate level of nicotine dependence as determined by the scoring on the Fagerstrom Test for Nicotine Dependence; (II) breath alcohol concentration greater than 0.05 g/210 L; (III) positive urine test for cocaine, opiates, and drugs other than cannabis; and (IV) meeting DSM-IV criteria of alcohol dependence.
13-1	2711-2714	The	_
13-2	2715-2724	exclusion	_
13-3	2725-2733	criteria	_
13-4	2734-2738	were	_
13-5	2739-2740	:	_
13-6	2741-2742	(	_
13-7	2743-2744	I	_
13-8	2745-2746	)	_
13-9	2747-2753	higher	_
13-10	2754-2758	than	_
13-11	2759-2767	moderate	_
13-12	2768-2773	level	_
13-13	2774-2776	of	_
13-14	2777-2785	nicotine	_
13-15	2786-2796	dependence	_
13-16	2797-2799	as	_
13-17	2800-2810	determined	_
13-18	2811-2813	by	_
13-19	2814-2817	the	_
13-20	2818-2825	scoring	_
13-21	2826-2828	on	_
13-22	2829-2832	the	_
13-23	2833-2843	Fagerstrom	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
13-24	2844-2848	Test	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
13-25	2849-2852	for	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
13-26	2853-2861	Nicotine	_
13-27	2862-2872	Dependence	http://maven.renci.org/NeuroBridge/neurobridge#PolysubstanceDependence
13-28	2873-2874	;	_
13-29	2875-2876	(	_
13-30	2877-2879	II	_
13-31	2880-2881	)	_
13-32	2882-2888	breath	_
13-33	2889-2896	alcohol	_
13-34	2897-2910	concentration	_
13-35	2911-2918	greater	_
13-36	2919-2923	than	_
13-37	2924-2928	0.05	_
13-38	2929-2934	g/210	_
13-39	2935-2936	L	_
13-40	2937-2938	;	_
13-41	2939-2940	(	_
13-42	2941-2944	III	_
13-43	2945-2946	)	_
13-44	2947-2955	positive	_
13-45	2956-2961	urine	_
13-46	2962-2966	test	_
13-47	2967-2970	for	_
13-48	2971-2978	cocaine	_
13-49	2979-2980	,	_
13-50	2981-2988	opiates	_
13-51	2989-2990	,	_
13-52	2991-2994	and	_
13-53	2995-3000	drugs	_
13-54	3001-3006	other	_
13-55	3007-3011	than	_
13-56	3012-3020	cannabis	_
13-57	3021-3022	;	_
13-58	3023-3026	and	_
13-59	3027-3028	(	_
13-60	3029-3031	IV	_
13-61	3032-3033	)	_
13-62	3034-3041	meeting	_
13-63	3042-3048	DSM-IV	_
13-64	3049-3057	criteria	_
13-65	3058-3060	of	_
13-66	3061-3068	alcohol	_
13-67	3069-3079	dependence	_
13-68	3080-3081	.	_

Text=Based on the inclusion/exclusion criteria, 23 CUD subjects and 676 potential non-drug-using subjects were identified from 900 participants.
14-1	3082-3087	Based	_
14-2	3088-3090	on	_
14-3	3091-3094	the	_
14-4	3095-3114	inclusion/exclusion	_
14-5	3115-3123	criteria	_
14-6	3124-3125	,	_
14-7	3126-3128	23	_
14-8	3129-3132	CUD	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
14-9	3133-3141	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
14-10	3142-3145	and	_
14-11	3146-3149	676	_
14-12	3150-3159	potential	_
14-13	3160-3174	non-drug-using	_
14-14	3175-3183	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
14-15	3184-3188	were	_
14-16	3189-3199	identified	_
14-17	3200-3204	from	_
14-18	3205-3208	900	_
14-19	3209-3221	participants	_
14-20	3222-3223	.	_

Text=Twenty-three non-drug-using controls were then selected from 676 non-drug-using subjects in order to match the 23 CUD subjects, in sex, age, education, alcohol use, tobacco use, and self-reported lifetime use of other non-cannabis drugs.
15-1	3224-3236	Twenty-three	_
15-2	3237-3251	non-drug-using	_
15-3	3252-3260	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
15-4	3261-3265	were	_
15-5	3266-3270	then	_
15-6	3271-3279	selected	_
15-7	3280-3284	from	_
15-8	3285-3288	676	_
15-9	3289-3303	non-drug-using	_
15-10	3304-3312	subjects	_
15-11	3313-3315	in	_
15-12	3316-3321	order	_
15-13	3322-3324	to	_
15-14	3325-3330	match	_
15-15	3331-3334	the	_
15-16	3335-3337	23	_
15-17	3338-3341	CUD	_
15-18	3342-3350	subjects	_
15-19	3351-3352	,	_
15-20	3353-3355	in	_
15-21	3356-3359	sex	_
15-22	3360-3361	,	_
15-23	3362-3365	age	_
15-24	3366-3367	,	_
15-25	3368-3377	education	_
15-26	3378-3379	,	_
15-27	3380-3387	alcohol	_
15-28	3388-3391	use	_
15-29	3392-3393	,	_
15-30	3394-3401	tobacco	_
15-31	3402-3405	use	_
15-32	3406-3407	,	_
15-33	3408-3411	and	_
15-34	3412-3425	self-reported	_
15-35	3426-3434	lifetime	_
15-36	3435-3438	use	_
15-37	3439-3441	of	_
15-38	3442-3447	other	_
15-39	3448-3460	non-cannabis	_
15-40	3461-3466	drugs	_
15-41	3467-3468	.	_

Text=Specifically, one control subject was selected to match one CUD subject, with sex as the first priority, age, and education as the second priority, and alcohol use, tobacco use, and self-reported lifetime use of other non-cannabis drugs as the third priority in matching.
16-1	3469-3481	Specifically	_
16-2	3482-3483	,	_
16-3	3484-3487	one	_
16-4	3488-3495	control	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
16-5	3496-3503	subject	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
16-6	3504-3507	was	_
16-7	3508-3516	selected	_
16-8	3517-3519	to	_
16-9	3520-3525	match	_
16-10	3526-3529	one	_
16-11	3530-3533	CUD	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse
16-12	3534-3541	subject	_
16-13	3542-3543	,	_
16-14	3544-3548	with	_
16-15	3549-3552	sex	_
16-16	3553-3555	as	_
16-17	3556-3559	the	_
16-18	3560-3565	first	_
16-19	3566-3574	priority	_
16-20	3575-3576	,	_
16-21	3577-3580	age	_
16-22	3581-3582	,	_
16-23	3583-3586	and	_
16-24	3587-3596	education	_
16-25	3597-3599	as	_
16-26	3600-3603	the	_
16-27	3604-3610	second	_
16-28	3611-3619	priority	_
16-29	3620-3621	,	_
16-30	3622-3625	and	_
16-31	3626-3633	alcohol	_
16-32	3634-3637	use	_
16-33	3638-3639	,	_
16-34	3640-3647	tobacco	_
16-35	3648-3651	use	_
16-36	3652-3653	,	_
16-37	3654-3657	and	_
16-38	3658-3671	self-reported	_
16-39	3672-3680	lifetime	_
16-40	3681-3684	use	_
16-41	3685-3687	of	_
16-42	3688-3693	other	_
16-43	3694-3706	non-cannabis	_
16-44	3707-3712	drugs	_
16-45	3713-3715	as	_
16-46	3716-3719	the	_
16-47	3720-3725	third	_
16-48	3726-3734	priority	_
16-49	3735-3737	in	_
16-50	3738-3746	matching	_
16-51	3747-3748	.	_

Text=See Table 1 for the demographic information of both groups.
17-1	3749-3752	See	_
17-2	3753-3758	Table	_
17-3	3759-3760	1	_
17-4	3761-3764	for	_
17-5	3765-3768	the	_
17-6	3769-3780	demographic	_
17-7	3781-3792	information	_
17-8	3793-3795	of	_
17-9	3796-3800	both	_
17-10	3801-3807	groups	_
17-11	3808-3809	.	_

Text=The two groups were not significantly different in age (t=0.4708, degrees of freedom [df] =44, p = 0.6401), sex (Fisher ’ s exact test p = 1, two-tail), education (t = 0, df = 44, p = 1), alcohol use (t = 0.2497, df = 44, p=0.8040), tobacco use (t = 0.5144, df = 44, p = 0.6096), and self-reported lifetime use on more than 10 occasions of any non-cannabis drug (Fisher ’ s exact test p> 0.1868, two-tail).
18-1	3810-3813	The	_
18-2	3814-3817	two	_
18-3	3818-3824	groups	_
18-4	3825-3829	were	_
18-5	3830-3833	not	_
18-6	3834-3847	significantly	_
18-7	3848-3857	different	_
18-8	3858-3860	in	_
18-9	3861-3864	age	_
18-10	3865-3866	(	_
18-11	3867-3875	t=0.4708	_
18-12	3876-3877	,	_
18-13	3878-3885	degrees	_
18-14	3886-3888	of	_
18-15	3889-3896	freedom	_
18-16	3897-3898	[	_
18-17	3899-3901	df	_
18-18	3902-3903	]	_
18-19	3904-3907	=44	_
18-20	3908-3909	,	_
18-21	3910-3911	p	_
18-22	3912-3913	=	_
18-23	3914-3920	0.6401	_
18-24	3921-3922	)	_
18-25	3923-3924	,	_
18-26	3925-3928	sex	_
18-27	3929-3930	(	_
18-28	3931-3937	Fisher	_
18-29	3938-3939	’	_
18-30	3940-3941	s	_
18-31	3942-3947	exact	_
18-32	3948-3952	test	_
18-33	3953-3954	p	_
18-34	3955-3956	=	_
18-35	3957-3958	1	_
18-36	3959-3960	,	_
18-37	3961-3969	two-tail	_
18-38	3970-3971	)	_
18-39	3972-3973	,	_
18-40	3974-3983	education	_
18-41	3984-3985	(	_
18-42	3986-3987	t	_
18-43	3988-3989	=	_
18-44	3990-3991	0	_
18-45	3992-3993	,	_
18-46	3994-3996	df	_
18-47	3997-3998	=	_
18-48	3999-4001	44	_
18-49	4002-4003	,	_
18-50	4004-4005	p	_
18-51	4006-4007	=	_
18-52	4008-4009	1	_
18-53	4010-4011	)	_
18-54	4012-4013	,	_
18-55	4014-4021	alcohol	_
18-56	4022-4025	use	_
18-57	4026-4027	(	_
18-58	4028-4029	t	_
18-59	4030-4031	=	_
18-60	4032-4038	0.2497	_
18-61	4039-4040	,	_
18-62	4041-4043	df	_
18-63	4044-4045	=	_
18-64	4046-4048	44	_
18-65	4049-4050	,	_
18-66	4051-4059	p=0.8040	_
18-67	4060-4061	)	_
18-68	4062-4063	,	_
18-69	4064-4071	tobacco	_
18-70	4072-4075	use	_
18-71	4076-4077	(	_
18-72	4078-4079	t	_
18-73	4080-4081	=	_
18-74	4082-4088	0.5144	_
18-75	4089-4090	,	_
18-76	4091-4093	df	_
18-77	4094-4095	=	_
18-78	4096-4098	44	_
18-79	4099-4100	,	_
18-80	4101-4102	p	_
18-81	4103-4104	=	_
18-82	4105-4111	0.6096	_
18-83	4112-4113	)	_
18-84	4114-4115	,	_
18-85	4116-4119	and	_
18-86	4120-4133	self-reported	_
18-87	4134-4142	lifetime	_
18-88	4143-4146	use	_
18-89	4147-4149	on	_
18-90	4150-4154	more	_
18-91	4155-4159	than	_
18-92	4160-4162	10	_
18-93	4163-4172	occasions	_
18-94	4173-4175	of	_
18-95	4176-4179	any	_
18-96	4180-4192	non-cannabis	_
18-97	4193-4197	drug	_
18-98	4198-4199	(	_
18-99	4200-4206	Fisher	_
18-100	4207-4208	’	_
18-101	4209-4210	s	_
18-102	4211-4216	exact	_
18-103	4217-4221	test	_
18-104	4222-4223	p	_
18-105	4224-4225	>	_
18-106	4226-4232	0.1868	_
18-107	4233-4234	,	_
18-108	4235-4243	two-tail	_
18-109	4244-4245	)	_
18-110	4246-4247	.	_

Text=The age of 17 years was used as the threshold of early-onset.
19-1	4248-4251	The	_
19-2	4252-4255	age	_
19-3	4256-4258	of	_
19-4	4259-4261	17	_
19-5	4262-4267	years	_
19-6	4268-4271	was	_
19-7	4272-4276	used	_
19-8	4277-4279	as	_
19-9	4280-4283	the	_
19-10	4284-4293	threshold	_
19-11	4294-4296	of	_
19-12	4297-4308	early-onset	_
19-13	4309-4310	.	_

Text=Based on this threshold, 16 CUD individuals belonged to the early-onset CUD subgroup (11 males, 6 females, 28.4 ± 3.4 years old, 15.0 ± 1.7 years of education) and the 7 remaining CUD individuals belonged to the late-onset CUD subgroup (6 males, 1 female, 27.6 ± 4.0 years old, 13.6 ± 1.7 years of education).
20-1	4311-4316	Based	_
20-2	4317-4319	on	_
20-3	4320-4324	this	_
20-4	4325-4334	threshold	_
20-5	4335-4336	,	_
20-6	4337-4339	16	_
20-7	4340-4343	CUD	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
20-8	4344-4355	individuals	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
20-9	4356-4364	belonged	_
20-10	4365-4367	to	_
20-11	4368-4371	the	_
20-12	4372-4383	early-onset	http://maven.renci.org/NeuroBridge/neurobridge#DelayedOnsetPostTraumaticStressDisorder
20-13	4384-4387	CUD	http://maven.renci.org/NeuroBridge/neurobridge#DelayedOnsetPostTraumaticStressDisorder
20-14	4388-4396	subgroup	http://maven.renci.org/NeuroBridge/neurobridge#DelayedOnsetPostTraumaticStressDisorder
20-15	4397-4398	(	_
20-16	4399-4401	11	_
20-17	4402-4407	males	_
20-18	4408-4409	,	_
20-19	4410-4411	6	_
20-20	4412-4419	females	_
20-21	4420-4421	,	_
20-22	4422-4426	28.4	_
20-23	4427-4428	±	_
20-24	4429-4432	3.4	_
20-25	4433-4438	years	_
20-26	4439-4442	old	_
20-27	4443-4444	,	_
20-28	4445-4449	15.0	_
20-29	4450-4451	±	_
20-30	4452-4455	1.7	_
20-31	4456-4461	years	_
20-32	4462-4464	of	_
20-33	4465-4474	education	_
20-34	4475-4476	)	_
20-35	4477-4480	and	_
20-36	4481-4484	the	_
20-37	4485-4486	7	_
20-38	4487-4496	remaining	_
20-39	4497-4500	CUD	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
20-40	4501-4512	individuals	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
20-41	4513-4521	belonged	_
20-42	4522-4524	to	_
20-43	4525-4528	the	_
20-44	4529-4539	late-onset	http://maven.renci.org/NeuroBridge/neurobridge#LateOnsetSchizophrenia
20-45	4540-4543	CUD	http://maven.renci.org/NeuroBridge/neurobridge#LateOnsetSchizophrenia
20-46	4544-4552	subgroup	http://maven.renci.org/NeuroBridge/neurobridge#LateOnsetSchizophrenia
20-47	4553-4554	(	_
20-48	4555-4556	6	_
20-49	4557-4562	males	_
20-50	4563-4564	,	_
20-51	4565-4566	1	_
20-52	4567-4573	female	_
20-53	4574-4575	,	_
20-54	4576-4580	27.6	_
20-55	4581-4582	±	_
20-56	4583-4586	4.0	_
20-57	4587-4592	years	_
20-58	4593-4596	old	_
20-59	4597-4598	,	_
20-60	4599-4603	13.6	_
20-61	4604-4605	±	_
20-62	4606-4609	1.7	_
20-63	4610-4615	years	_
20-64	4616-4618	of	_
20-65	4619-4628	education	_
20-66	4629-4630	)	_
20-67	4631-4632	.	_

Text=The two CUD subgroups showed a trend significant difference in education (t = 1.8389, df = 21, p = 0.0801), no significant difference in alcohol use (t = 0.1417, df=21, p = 0.8887), and no significant difference in tobacco use (t = 0.5923, df = 21, p = 0.5923).
21-1	4633-4636	The	_
21-2	4637-4640	two	_
21-3	4641-4644	CUD	_
21-4	4645-4654	subgroups	_
21-5	4655-4661	showed	_
21-6	4662-4663	a	_
21-7	4664-4669	trend	_
21-8	4670-4681	significant	_
21-9	4682-4692	difference	_
21-10	4693-4695	in	_
21-11	4696-4705	education	_
21-12	4706-4707	(	_
21-13	4708-4709	t	_
21-14	4710-4711	=	_
21-15	4712-4718	1.8389	_
21-16	4719-4720	,	_
21-17	4721-4723	df	_
21-18	4724-4725	=	_
21-19	4726-4728	21	_
21-20	4729-4730	,	_
21-21	4731-4732	p	_
21-22	4733-4734	=	_
21-23	4735-4741	0.0801	_
21-24	4742-4743	)	_
21-25	4744-4745	,	_
21-26	4746-4748	no	_
21-27	4749-4760	significant	_
21-28	4761-4771	difference	_
21-29	4772-4774	in	_
21-30	4775-4782	alcohol	_
21-31	4783-4786	use	_
21-32	4787-4788	(	_
21-33	4789-4790	t	_
21-34	4791-4792	=	_
21-35	4793-4799	0.1417	_
21-36	4800-4801	,	_
21-37	4802-4807	df=21	_
21-38	4808-4809	,	_
21-39	4810-4811	p	_
21-40	4812-4813	=	_
21-41	4814-4820	0.8887	_
21-42	4821-4822	)	_
21-43	4823-4824	,	_
21-44	4825-4828	and	_
21-45	4829-4831	no	_
21-46	4832-4843	significant	_
21-47	4844-4854	difference	_
21-48	4855-4857	in	_
21-49	4858-4865	tobacco	_
21-50	4866-4869	use	_
21-51	4870-4871	(	_
21-52	4872-4873	t	_
21-53	4874-4875	=	_
21-54	4876-4882	0.5923	_
21-55	4883-4884	,	_
21-56	4885-4887	df	_
21-57	4888-4889	=	_
21-58	4890-4892	21	_
21-59	4893-4894	,	_
21-60	4895-4896	p	_
21-61	4897-4898	=	_
21-62	4899-4905	0.5923	_
21-63	4906-4907	)	_
21-64	4908-4909	.	_

Text=In-scanner working memory task The HCP n-back working memory task used pictures of faces, places, tools and body parts as the stimuli to assess WM.
22-1	4910-4920	In-scanner	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
22-2	4921-4928	working	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
22-3	4929-4935	memory	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
22-4	4936-4940	task	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
22-5	4941-4944	The	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
22-6	4945-4948	HCP	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
22-7	4949-4955	n-back	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
22-8	4956-4963	working	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
22-9	4964-4970	memory	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
22-10	4971-4975	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
22-11	4976-4980	used	_
22-12	4981-4989	pictures	_
22-13	4990-4992	of	_
22-14	4993-4998	faces	_
22-15	4999-5000	,	_
22-16	5001-5007	places	_
22-17	5008-5009	,	_
22-18	5010-5015	tools	_
22-19	5016-5019	and	_
22-20	5020-5024	body	_
22-21	5025-5030	parts	_
22-22	5031-5033	as	_
22-23	5034-5037	the	_
22-24	5038-5045	stimuli	_
22-25	5046-5048	to	_
22-26	5049-5055	assess	_
22-27	5056-5058	WM	_
22-28	5059-5060	.	_

Text=Two n-back fMRI runs were conducted.
23-1	5061-5064	Two	_
23-2	5065-5071	n-back	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
23-3	5072-5076	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
23-4	5077-5081	runs	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
23-5	5082-5086	were	_
23-6	5087-5096	conducted	_
23-7	5097-5098	.	_

Text=Each run consists of four “ 2-back ” task blocks (10 trials of 2.5 s each per block, block duration = 25 s), four “ 0-back ” task blocks (10 trials of 2.5 s each per block, block duration = 25 s) and four fixation blocks (block duration = 15 s).
24-1	5099-5103	Each	_
24-2	5104-5107	run	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
24-3	5108-5116	consists	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
24-4	5117-5119	of	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
24-5	5120-5124	four	_
24-6	5125-5126	“	_
24-7	5127-5133	2-back	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
24-8	5134-5135	”	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
24-9	5136-5140	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
24-10	5141-5147	blocks	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
24-11	5148-5149	(	_
24-12	5150-5152	10	_
24-13	5153-5159	trials	_
24-14	5160-5162	of	_
24-15	5163-5166	2.5	_
24-16	5167-5168	s	_
24-17	5169-5173	each	_
24-18	5174-5177	per	_
24-19	5178-5183	block	_
24-20	5184-5185	,	_
24-21	5186-5191	block	_
24-22	5192-5200	duration	_
24-23	5201-5202	=	_
24-24	5203-5205	25	_
24-25	5206-5207	s	_
24-26	5208-5209	)	_
24-27	5210-5211	,	_
24-28	5212-5216	four	_
24-29	5217-5218	“	_
24-30	5219-5225	0-back	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
24-31	5226-5227	”	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
24-32	5228-5232	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
24-33	5233-5239	blocks	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
24-34	5240-5241	(	_
24-35	5242-5244	10	_
24-36	5245-5251	trials	_
24-37	5252-5254	of	_
24-38	5255-5258	2.5	_
24-39	5259-5260	s	_
24-40	5261-5265	each	_
24-41	5266-5269	per	_
24-42	5270-5275	block	_
24-43	5276-5277	,	_
24-44	5278-5283	block	_
24-45	5284-5292	duration	_
24-46	5293-5294	=	_
24-47	5295-5297	25	_
24-48	5298-5299	s	_
24-49	5300-5301	)	_
24-50	5302-5305	and	_
24-51	5306-5310	four	_
24-52	5311-5319	fixation	_
24-53	5320-5326	blocks	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
24-54	5327-5328	(	_
24-55	5329-5334	block	_
24-56	5335-5343	duration	_
24-57	5344-5345	=	_
24-58	5346-5348	15	_
24-59	5349-5350	s	_
24-60	5351-5352	)	_
24-61	5353-5354	.	_

Text=All the stimulus types were used in each task type, but the order of stimulus types was random.
25-1	5355-5358	All	_
25-2	5359-5362	the	_
25-3	5363-5371	stimulus	_
25-4	5372-5377	types	_
25-5	5378-5382	were	_
25-6	5383-5387	used	_
25-7	5388-5390	in	_
25-8	5391-5395	each	_
25-9	5396-5400	task	_
25-10	5401-5405	type	_
25-11	5406-5407	,	_
25-12	5408-5411	but	_
25-13	5412-5415	the	_
25-14	5416-5421	order	_
25-15	5422-5424	of	_
25-16	5425-5433	stimulus	_
25-17	5434-5439	types	_
25-18	5440-5443	was	_
25-19	5444-5450	random	_
25-20	5451-5452	.	_

Text=A 2.5 s cue indicated the task type (and target for 0-back) at the start of the block.
26-1	5453-5454	A	_
26-2	5455-5458	2.5	_
26-3	5459-5460	s	_
26-4	5461-5464	cue	_
26-5	5465-5474	indicated	_
26-6	5475-5478	the	_
26-7	5479-5483	task	_
26-8	5484-5488	type	_
26-9	5489-5490	(	_
26-10	5491-5494	and	_
26-11	5495-5501	target	_
26-12	5502-5505	for	_
26-13	5506-5512	0-back	_
26-14	5513-5514	)	_
26-15	5515-5517	at	_
26-16	5518-5521	the	_
26-17	5522-5527	start	_
26-18	5528-5530	of	_
26-19	5531-5534	the	_
26-20	5535-5540	block	_
26-21	5541-5542	.	_

Text=On each trial, the stimulus was presented for 2 s, followed by a 500 ms inter-trial-interval.
27-1	5543-5545	On	_
27-2	5546-5550	each	_
27-3	5551-5556	trial	_
27-4	5557-5558	,	_
27-5	5559-5562	the	_
27-6	5563-5571	stimulus	_
27-7	5572-5575	was	_
27-8	5576-5585	presented	_
27-9	5586-5589	for	_
27-10	5590-5591	2	_
27-11	5592-5593	s	_
27-12	5594-5595	,	_
27-13	5596-5604	followed	_
27-14	5605-5607	by	_
27-15	5608-5609	a	_
27-16	5610-5613	500	_
27-17	5614-5616	ms	_
27-18	5617-5637	inter-trial-interval	_
27-19	5638-5639	.	_

Text=Two or three trials in each task block presented non-target lures.
28-1	5640-5643	Two	_
28-2	5644-5646	or	_
28-3	5647-5652	three	_
28-4	5653-5659	trials	_
28-5	5660-5662	in	_
28-6	5663-5667	each	_
28-7	5668-5672	task	_
28-8	5673-5678	block	_
28-9	5679-5688	presented	_
28-10	5689-5699	non-target	_
28-11	5700-5705	lures	_
28-12	5706-5707	.	_

Text=Out-scanner tasks testing executive function/working memory Dimensional change card sort HCP used dimensional change card task (about 4 min) to measure executive function/cognitive flexibility.
29-1	5708-5719	Out-scanner	_
29-2	5720-5725	tasks	_
29-3	5726-5733	testing	_
29-4	5734-5743	executive	_
29-5	5744-5760	function/working	_
29-6	5761-5767	memory	_
29-7	5768-5779	Dimensional	_
29-8	5780-5786	change	_
29-9	5787-5791	card	_
29-10	5792-5796	sort	_
29-11	5797-5800	HCP	_
29-12	5801-5805	used	_
29-13	5806-5817	dimensional	_
29-14	5818-5824	change	_
29-15	5825-5829	card	_
29-16	5830-5834	task	_
29-17	5835-5836	(	_
29-18	5837-5842	about	_
29-19	5843-5844	4	_
29-20	5845-5848	min	_
29-21	5849-5850	)	_
29-22	5851-5853	to	_
29-23	5854-5861	measure	_
29-24	5862-5871	executive	_
29-25	5872-5890	function/cognitive	_
29-26	5891-5902	flexibility	_
29-27	5903-5904	.	_

Text=Two target pictures were presented that vary along two dimensions (e.g., shape and color).
30-1	5905-5908	Two	_
30-2	5909-5915	target	_
30-3	5916-5924	pictures	_
30-4	5925-5929	were	_
30-5	5930-5939	presented	_
30-6	5940-5944	that	_
30-7	5945-5949	vary	_
30-8	5950-5955	along	_
30-9	5956-5959	two	_
30-10	5960-5970	dimensions	_
30-11	5971-5972	(	_
30-12	5973-5977	e.g.	_
30-13	5978-5979	,	_
30-14	5980-5985	shape	_
30-15	5986-5989	and	_
30-16	5990-5995	color	_
30-17	5996-5997	)	_
30-18	5998-5999	.	_

Text=Participants were asked to match a series of bivalent test pictures (e.g., yellow balls and blue trucks) to the target pictures, first according to one dimension (e.g., color) and then, after a number of trials, according to the other dimension (e.g., shape).
31-1	6000-6012	Participants	_
31-2	6013-6017	were	_
31-3	6018-6023	asked	_
31-4	6024-6026	to	_
31-5	6027-6032	match	_
31-6	6033-6034	a	_
31-7	6035-6041	series	_
31-8	6042-6044	of	_
31-9	6045-6053	bivalent	_
31-10	6054-6058	test	_
31-11	6059-6067	pictures	_
31-12	6068-6069	(	_
31-13	6070-6074	e.g.	_
31-14	6075-6076	,	_
31-15	6077-6083	yellow	_
31-16	6084-6089	balls	_
31-17	6090-6093	and	_
31-18	6094-6098	blue	_
31-19	6099-6105	trucks	_
31-20	6106-6107	)	_
31-21	6108-6110	to	_
31-22	6111-6114	the	_
31-23	6115-6121	target	_
31-24	6122-6130	pictures	_
31-25	6131-6132	,	_
31-26	6133-6138	first	_
31-27	6139-6148	according	_
31-28	6149-6151	to	_
31-29	6152-6155	one	_
31-30	6156-6165	dimension	_
31-31	6166-6167	(	_
31-32	6168-6172	e.g.	_
31-33	6173-6174	,	_
31-34	6175-6180	color	_
31-35	6181-6182	)	_
31-36	6183-6186	and	_
31-37	6187-6191	then	_
31-38	6192-6193	,	_
31-39	6194-6199	after	_
31-40	6200-6201	a	_
31-41	6202-6208	number	_
31-42	6209-6211	of	_
31-43	6212-6218	trials	_
31-44	6219-6220	,	_
31-45	6221-6230	according	_
31-46	6231-6233	to	_
31-47	6234-6237	the	_
31-48	6238-6243	other	_
31-49	6244-6253	dimension	_
31-50	6254-6255	(	_
31-51	6256-6260	e.g.	_
31-52	6261-6262	,	_
31-53	6263-6268	shape	_
31-54	6269-6270	)	_
31-55	6271-6272	.	_

Text=Some “ Switch ” trials, in which the participant must change the dimension being matched, were used in order to test cognitive flexibility.
32-1	6273-6277	Some	_
32-2	6278-6279	“	_
32-3	6280-6286	Switch	_
32-4	6287-6288	”	_
32-5	6289-6295	trials	_
32-6	6296-6297	,	_
32-7	6298-6300	in	_
32-8	6301-6306	which	_
32-9	6307-6310	the	_
32-10	6311-6322	participant	_
32-11	6323-6327	must	_
32-12	6328-6334	change	_
32-13	6335-6338	the	_
32-14	6339-6348	dimension	_
32-15	6349-6354	being	_
32-16	6355-6362	matched	_
32-17	6363-6364	,	_
32-18	6365-6369	were	_
32-19	6370-6374	used	_
32-20	6375-6377	in	_
32-21	6378-6383	order	_
32-22	6384-6386	to	_
32-23	6387-6391	test	_
32-24	6392-6401	cognitive	_
32-25	6402-6413	flexibility	_
32-26	6414-6415	.	_

Text=Scoring was based on a combination of accuracy and reaction time.
33-1	6416-6423	Scoring	_
33-2	6424-6427	was	_
33-3	6428-6433	based	_
33-4	6434-6436	on	_
33-5	6437-6438	a	_
33-6	6439-6450	combination	_
33-7	6451-6453	of	_
33-8	6454-6462	accuracy	_
33-9	6463-6466	and	_
33-10	6467-6475	reaction	_
33-11	6476-6480	time	_
33-12	6481-6482	.	_

Text=Flanker task HCP used the Flanker task (about 3 min) to jointly measure attention and inhibitory control.
34-1	6483-6490	Flanker	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
34-2	6491-6495	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
34-3	6496-6499	HCP	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
34-4	6500-6504	used	_
34-5	6505-6508	the	_
34-6	6509-6516	Flanker	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
34-7	6517-6521	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
34-8	6522-6523	(	_
34-9	6524-6529	about	_
34-10	6530-6531	3	_
34-11	6532-6535	min	_
34-12	6536-6537	)	_
34-13	6538-6540	to	_
34-14	6541-6548	jointly	_
34-15	6549-6556	measure	_
34-16	6557-6566	attention	_
34-17	6567-6570	and	_
34-18	6571-6581	inhibitory	_
34-19	6582-6589	control	_
34-20	6590-6591	.	_

Text=During the test, the participant was requested to focus on a given stimulus while inhibiting attention to stimuli (arrows) flanking it.
35-1	6592-6598	During	_
35-2	6599-6602	the	_
35-3	6603-6607	test	_
35-4	6608-6609	,	_
35-5	6610-6613	the	_
35-6	6614-6625	participant	_
35-7	6626-6629	was	_
35-8	6630-6639	requested	_
35-9	6640-6642	to	_
35-10	6643-6648	focus	_
35-11	6649-6651	on	_
35-12	6652-6653	a	_
35-13	6654-6659	given	_
35-14	6660-6668	stimulus	_
35-15	6669-6674	while	_
35-16	6675-6685	inhibiting	_
35-17	6686-6695	attention	_
35-18	6696-6698	to	_
35-19	6699-6706	stimuli	_
35-20	6707-6708	(	_
35-21	6709-6715	arrows	_
35-22	6716-6717	)	_
35-23	6718-6726	flanking	_
35-24	6727-6729	it	_
35-25	6730-6731	.	_

Text=Sometimes the middle stimulus is pointing in the same direction as the “ flankers ” (congruent) and sometimes in the opposite direction (incongruent).
36-1	6732-6741	Sometimes	_
36-2	6742-6745	the	_
36-3	6746-6752	middle	_
36-4	6753-6761	stimulus	_
36-5	6762-6764	is	_
36-6	6765-6773	pointing	_
36-7	6774-6776	in	_
36-8	6777-6780	the	_
36-9	6781-6785	same	_
36-10	6786-6795	direction	_
36-11	6796-6798	as	_
36-12	6799-6802	the	_
36-13	6803-6804	“	_
36-14	6805-6813	flankers	_
36-15	6814-6815	”	_
36-16	6816-6817	(	_
36-17	6818-6827	congruent	_
36-18	6828-6829	)	_
36-19	6830-6833	and	_
36-20	6834-6843	sometimes	_
36-21	6844-6846	in	_
36-22	6847-6850	the	_
36-23	6851-6859	opposite	_
36-24	6860-6869	direction	_
36-25	6870-6871	(	_
36-26	6872-6883	incongruent	_
36-27	6884-6885	)	_
36-28	6886-6887	.	_

Text=Scoring was based on a combination of accuracy and reaction time.
37-1	6888-6895	Scoring	_
37-2	6896-6899	was	_
37-3	6900-6905	based	_
37-4	6906-6908	on	_
37-5	6909-6910	a	_
37-6	6911-6922	combination	_
37-7	6923-6925	of	_
37-8	6926-6934	accuracy	_
37-9	6935-6938	and	_
37-10	6939-6947	reaction	_
37-11	6948-6952	time	_
37-12	6953-6954	.	_

Text=List sorting HCP used the list sorting task to assess working memory.
38-1	6955-6959	List	http://maven.renci.org/NeuroBridge/neurobridge#RatingScale
38-2	6960-6967	sorting	http://maven.renci.org/NeuroBridge/neurobridge#RatingScale
38-3	6968-6971	HCP	http://maven.renci.org/NeuroBridge/neurobridge#RatingScale
38-4	6972-6976	used	_
38-5	6977-6980	the	_
38-6	6981-6985	list	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
38-7	6986-6993	sorting	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
38-8	6994-6998	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
38-9	6999-7001	to	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
38-10	7002-7008	assess	_
38-11	7009-7016	working	_
38-12	7017-7023	memory	_
38-13	7024-7025	.	_

Text=With two different conditions (1-List and 2-List), this task requires the participant to sequence different visually- and orally-presented stimuli.
39-1	7026-7030	With	_
39-2	7031-7034	two	_
39-3	7035-7044	different	_
39-4	7045-7055	conditions	_
39-5	7056-7057	(	_
39-6	7058-7064	1-List	_
39-7	7065-7068	and	_
39-8	7069-7075	2-List	_
39-9	7076-7077	)	_
39-10	7078-7079	,	_
39-11	7080-7084	this	_
39-12	7085-7089	task	_
39-13	7090-7098	requires	_
39-14	7099-7102	the	_
39-15	7103-7114	participant	_
39-16	7115-7117	to	_
39-17	7118-7126	sequence	_
39-18	7127-7136	different	_
39-19	7137-7146	visually-	_
39-20	7147-7150	and	_
39-21	7151-7167	orally-presented	_
39-22	7168-7175	stimuli	_
39-23	7176-7177	.	_

Text=Pictures of different foods and animals were displayed with both a sound clip and written text that name the item.
40-1	7178-7186	Pictures	_
40-2	7187-7189	of	_
40-3	7190-7199	different	_
40-4	7200-7205	foods	_
40-5	7206-7209	and	_
40-6	7210-7217	animals	_
40-7	7218-7222	were	_
40-8	7223-7232	displayed	_
40-9	7233-7237	with	_
40-10	7238-7242	both	_
40-11	7243-7244	a	_
40-12	7245-7250	sound	_
40-13	7251-7255	clip	_
40-14	7256-7259	and	_
40-15	7260-7267	written	_
40-16	7268-7272	text	_
40-17	7273-7277	that	_
40-18	7278-7282	name	_
40-19	7283-7286	the	_
40-20	7287-7291	item	_
40-21	7292-7293	.	_

Text=In the 1-List condition, participants were required to order a series of objects (either food or animals) in size order from smallest to largest.
41-1	7294-7296	In	_
41-2	7297-7300	the	_
41-3	7301-7307	1-List	_
41-4	7308-7317	condition	_
41-5	7318-7319	,	_
41-6	7320-7332	participants	_
41-7	7333-7337	were	_
41-8	7338-7346	required	_
41-9	7347-7349	to	_
41-10	7350-7355	order	_
41-11	7356-7357	a	_
41-12	7358-7364	series	_
41-13	7365-7367	of	_
41-14	7368-7375	objects	_
41-15	7376-7377	(	_
41-16	7378-7384	either	_
41-17	7385-7389	food	_
41-18	7390-7392	or	_
41-19	7393-7400	animals	_
41-20	7401-7402	)	_
41-21	7403-7405	in	_
41-22	7406-7410	size	_
41-23	7411-7416	order	_
41-24	7417-7421	from	_
41-25	7422-7430	smallest	_
41-26	7431-7433	to	_
41-27	7434-7441	largest	_
41-28	7442-7443	.	_

Text=In the 2-List condition, participants were presented both food and animals and are asked to report the food in size order, followed by the animals in size order.
42-1	7444-7446	In	_
42-2	7447-7450	the	_
42-3	7451-7457	2-List	_
42-4	7458-7467	condition	_
42-5	7468-7469	,	_
42-6	7470-7482	participants	_
42-7	7483-7487	were	_
42-8	7488-7497	presented	_
42-9	7498-7502	both	_
42-10	7503-7507	food	_
42-11	7508-7511	and	_
42-12	7512-7519	animals	_
42-13	7520-7523	and	_
42-14	7524-7527	are	_
42-15	7528-7533	asked	_
42-16	7534-7536	to	_
42-17	7537-7543	report	_
42-18	7544-7547	the	_
42-19	7548-7552	food	_
42-20	7553-7555	in	_
42-21	7556-7560	size	_
42-22	7561-7566	order	_
42-23	7567-7568	,	_
42-24	7569-7577	followed	_
42-25	7578-7580	by	_
42-26	7581-7584	the	_
42-27	7585-7592	animals	_
42-28	7593-7595	in	_
42-29	7596-7600	size	_
42-30	7601-7606	order	_
42-31	7607-7608	.	_

Text=fMRI data acquisition As described in, whole-brain echo-planar imaging acquisitions were acquired with a 32-channel head coil on a modified 3 T Siemens Skyra scanner (Erlangen, Germany), with repetition time = 720 ms, echo time = 33.1 ms, flip angle = 52°, band- width = 2290 Hz/pixel, in-plane field-of-view = 208 mm × 180 mm, 72 slices, 2.0 mm isotropic voxels, multi-band acceleration factor of 8.
43-1	7609-7613	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
43-2	7614-7618	data	_
43-3	7619-7630	acquisition	_
43-4	7631-7633	As	_
43-5	7634-7643	described	_
43-6	7644-7646	in	_
43-7	7647-7648	,	_
43-8	7649-7660	whole-brain	_
43-9	7661-7672	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
43-10	7673-7680	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
43-11	7681-7693	acquisitions	_
43-12	7694-7698	were	_
43-13	7699-7707	acquired	_
43-14	7708-7712	with	_
43-15	7713-7714	a	_
43-16	7715-7725	32-channel	_
43-17	7726-7730	head	_
43-18	7731-7735	coil	_
43-19	7736-7738	on	_
43-20	7739-7740	a	_
43-21	7741-7749	modified	_
43-22	7750-7751	3	_
43-23	7752-7753	T	_
43-24	7754-7761	Siemens	_
43-25	7762-7767	Skyra	_
43-26	7768-7775	scanner	_
43-27	7776-7777	(	_
43-28	7778-7786	Erlangen	_
43-29	7787-7788	,	_
43-30	7789-7796	Germany	_
43-31	7797-7798	)	_
43-32	7799-7800	,	_
43-33	7801-7805	with	_
43-34	7806-7816	repetition	_
43-35	7817-7821	time	_
43-36	7822-7823	=	_
43-37	7824-7827	720	_
43-38	7828-7830	ms	_
43-39	7831-7832	,	_
43-40	7833-7837	echo	_
43-41	7838-7842	time	_
43-42	7843-7844	=	_
43-43	7845-7849	33.1	_
43-44	7850-7852	ms	_
43-45	7853-7854	,	_
43-46	7855-7859	flip	_
43-47	7860-7865	angle	_
43-48	7866-7867	=	_
43-49	7868-7871	52°	_
43-50	7872-7873	,	_
43-51	7874-7879	band-	_
43-52	7880-7885	width	_
43-53	7886-7887	=	_
43-54	7888-7892	2290	_
43-55	7893-7901	Hz/pixel	_
43-56	7902-7903	,	_
43-57	7904-7912	in-plane	_
43-58	7913-7926	field-of-view	_
43-59	7927-7928	=	_
43-60	7929-7932	208	_
43-61	7933-7935	mm	_
43-62	7936-7937	×	_
43-63	7938-7941	180	_
43-64	7942-7944	mm	_
43-65	7945-7946	,	_
43-66	7947-7949	72	_
43-67	7950-7956	slices	_
43-68	7957-7958	,	_
43-69	7959-7962	2.0	_
43-70	7963-7965	mm	_
43-71	7966-7975	isotropic	_
43-72	7976-7982	voxels	_
43-73	7983-7984	,	_
43-74	7985-7995	multi-band	_
43-75	7996-8008	acceleration	_
43-76	8009-8015	factor	_
43-77	8016-8018	of	_
43-78	8019-8020	8	_
43-79	8021-8022	.	_

Text=Two fMRI runs, with left-to-right and right-to-left phase encodings, respectively, were acquired, preprocessed and concatenated for DCM analysis.
44-1	8023-8026	Two	_
44-2	8027-8031	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
44-3	8032-8036	runs	_
44-4	8037-8038	,	_
44-5	8039-8043	with	_
44-6	8044-8057	left-to-right	_
44-7	8058-8061	and	_
44-8	8062-8075	right-to-left	_
44-9	8076-8081	phase	_
44-10	8082-8091	encodings	_
44-11	8092-8093	,	_
44-12	8094-8106	respectively	_
44-13	8107-8108	,	_
44-14	8109-8113	were	_
44-15	8114-8122	acquired	_
44-16	8123-8124	,	_
44-17	8125-8137	preprocessed	_
44-18	8138-8141	and	_
44-19	8142-8154	concatenated	_
44-20	8155-8158	for	_
44-21	8159-8162	DCM	_
44-22	8163-8171	analysis	_
44-23	8172-8173	.	_

Text=fMRI preprocessing Per, fMRI data were “ minimally ” preprocessed to implement gradient unwarping, motion correction, fieldmap-based EPI distortion correction, brain-boundary-based registration of EPI to structural T1-weighted scan, non-linear registration into standard MNI152 space, and grand-mean intensity normalization (Functional Pipelines v3.4.0; v3.12.0; v3.13.2).
45-1	8174-8178	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
45-2	8179-8192	preprocessing	_
45-3	8193-8196	Per	_
45-4	8197-8198	,	_
45-5	8199-8203	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
45-6	8204-8208	data	_
45-7	8209-8213	were	_
45-8	8214-8215	“	_
45-9	8216-8225	minimally	_
45-10	8226-8227	”	_
45-11	8228-8240	preprocessed	_
45-12	8241-8243	to	_
45-13	8244-8253	implement	_
45-14	8254-8262	gradient	_
45-15	8263-8272	unwarping	_
45-16	8273-8274	,	_
45-17	8275-8281	motion	_
45-18	8282-8292	correction	_
45-19	8293-8294	,	_
45-20	8295-8309	fieldmap-based	_
45-21	8310-8313	EPI	_
45-22	8314-8324	distortion	_
45-23	8325-8335	correction	_
45-24	8336-8337	,	_
45-25	8338-8358	brain-boundary-based	_
45-26	8359-8371	registration	_
45-27	8372-8374	of	_
45-28	8375-8378	EPI	_
45-29	8379-8381	to	_
45-30	8382-8392	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
45-31	8393-8404	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-32	8405-8409	scan	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-33	8410-8411	,	_
45-34	8412-8422	non-linear	_
45-35	8423-8435	registration	_
45-36	8436-8440	into	_
45-37	8441-8449	standard	_
45-38	8450-8456	MNI152	_
45-39	8457-8462	space	_
45-40	8463-8464	,	_
45-41	8465-8468	and	_
45-42	8469-8479	grand-mean	_
45-43	8480-8489	intensity	_
45-44	8490-8503	normalization	_
45-45	8504-8505	(	_
45-46	8506-8516	Functional	_
45-47	8517-8526	Pipelines	_
45-48	8527-8533	v3.4.0	_
45-49	8534-8535	;	_
45-50	8536-8543	v3.12.0	_
45-51	8544-8545	;	_
45-52	8546-8553	v3.13.2	_
45-53	8554-8555	)	_
45-54	8556-8557	.	_

Text=The voxel size of the minimally- processed data is [2 × 2 × 2] mm.
46-1	8558-8561	The	_
46-2	8562-8567	voxel	_
46-3	8568-8572	size	_
46-4	8573-8575	of	_
46-5	8576-8579	the	_
46-6	8580-8590	minimally-	_
46-7	8591-8600	processed	_
46-8	8601-8605	data	_
46-9	8606-8608	is	_
46-10	8609-8610	[	_
46-11	8611-8612	2	_
46-12	8613-8614	×	_
46-13	8615-8616	2	_
46-14	8617-8618	×	_
46-15	8619-8620	2	_
46-16	8621-8622	]	_
46-17	8623-8625	mm	_
46-18	8626-8627	.	_

Text=Twelve head motion correction parameters were released by HCP.
47-1	8628-8634	Twelve	_
47-2	8635-8639	head	_
47-3	8640-8646	motion	_
47-4	8647-8657	correction	_
47-5	8658-8668	parameters	_
47-6	8669-8673	were	_
47-7	8674-8682	released	_
47-8	8683-8685	by	_
47-9	8686-8689	HCP	_
47-10	8690-8691	.	_

Text=See Table 2 for the detailed information of these parameters for both groups.
48-1	8692-8695	See	_
48-2	8696-8701	Table	_
48-3	8702-8703	2	_
48-4	8704-8707	for	_
48-5	8708-8711	the	_
48-6	8712-8720	detailed	_
48-7	8721-8732	information	_
48-8	8733-8735	of	_
48-9	8736-8741	these	_
48-10	8742-8752	parameters	_
48-11	8753-8756	for	_
48-12	8757-8761	both	_
48-13	8762-8768	groups	_
48-14	8769-8770	.	_

Text=For each fMRI run, we quantified these head motion parameters using cumulative value and maximal value.
49-1	8771-8774	For	_
49-2	8775-8779	each	_
49-3	8780-8784	fMRI	_
49-4	8785-8788	run	_
49-5	8789-8790	,	_
49-6	8791-8793	we	_
49-7	8794-8804	quantified	_
49-8	8805-8810	these	_
49-9	8811-8815	head	_
49-10	8816-8822	motion	_
49-11	8823-8833	parameters	_
49-12	8834-8839	using	_
49-13	8840-8850	cumulative	_
49-14	8851-8856	value	_
49-15	8857-8860	and	_
49-16	8861-8868	maximal	_
49-17	8869-8874	value	_
49-18	8875-8876	.	_

Text=For each motion parameter, the corresponding cumulative value and maximal value were computed as the summation and the maximum respectively, of the absolute values of this motion parameter across the entire run.
50-1	8877-8880	For	_
50-2	8881-8885	each	_
50-3	8886-8892	motion	_
50-4	8893-8902	parameter	_
50-5	8903-8904	,	_
50-6	8905-8908	the	_
50-7	8909-8922	corresponding	_
50-8	8923-8933	cumulative	_
50-9	8934-8939	value	_
50-10	8940-8943	and	_
50-11	8944-8951	maximal	_
50-12	8952-8957	value	_
50-13	8958-8962	were	_
50-14	8963-8971	computed	_
50-15	8972-8974	as	_
50-16	8975-8978	the	_
50-17	8979-8988	summation	_
50-18	8989-8992	and	_
50-19	8993-8996	the	_
50-20	8997-9004	maximum	_
50-21	9005-9017	respectively	_
50-22	9018-9019	,	_
50-23	9020-9022	of	_
50-24	9023-9026	the	_
50-25	9027-9035	absolute	_
50-26	9036-9042	values	_
50-27	9043-9045	of	_
50-28	9046-9050	this	_
50-29	9051-9057	motion	_
50-30	9058-9067	parameter	_
50-31	9068-9074	across	_
50-32	9075-9078	the	_
50-33	9079-9085	entire	_
50-34	9086-9089	run	_
50-35	9090-9091	.	_

Text=For each subject, the cumulative value and maximal value were computed as the mean and the maximum respectively, across the left-to-right phase-encoding fMRI run and right- to-left phase encoding fMRI run.
51-1	9092-9095	For	_
51-2	9096-9100	each	_
51-3	9101-9108	subject	_
51-4	9109-9110	,	_
51-5	9111-9114	the	_
51-6	9115-9125	cumulative	_
51-7	9126-9131	value	_
51-8	9132-9135	and	_
51-9	9136-9143	maximal	_
51-10	9144-9149	value	_
51-11	9150-9154	were	_
51-12	9155-9163	computed	_
51-13	9164-9166	as	_
51-14	9167-9170	the	_
51-15	9171-9175	mean	_
51-16	9176-9179	and	_
51-17	9180-9183	the	_
51-18	9184-9191	maximum	_
51-19	9192-9204	respectively	_
51-20	9205-9206	,	_
51-21	9207-9213	across	_
51-22	9214-9217	the	_
51-23	9218-9231	left-to-right	_
51-24	9232-9246	phase-encoding	_
51-25	9247-9251	fMRI	_
51-26	9252-9255	run	_
51-27	9256-9259	and	_
51-28	9260-9266	right-	_
51-29	9267-9274	to-left	_
51-30	9275-9280	phase	_
51-31	9281-9289	encoding	_
51-32	9290-9294	fMRI	_
51-33	9295-9298	run	_
51-34	9299-9300	.	_

Text=As shown in Table 2, none of the differences between groups for the cumulative head motion value was statistically significant after Bonferroni correction (corrected p> 0.95).
52-1	9301-9303	As	_
52-2	9304-9309	shown	_
52-3	9310-9312	in	_
52-4	9313-9318	Table	_
52-5	9319-9320	2	_
52-6	9321-9322	,	_
52-7	9323-9327	none	_
52-8	9328-9330	of	_
52-9	9331-9334	the	_
52-10	9335-9346	differences	_
52-11	9347-9354	between	_
52-12	9355-9361	groups	_
52-13	9362-9365	for	_
52-14	9366-9369	the	_
52-15	9370-9380	cumulative	_
52-16	9381-9385	head	_
52-17	9386-9392	motion	_
52-18	9393-9398	value	_
52-19	9399-9402	was	_
52-20	9403-9416	statistically	_
52-21	9417-9428	significant	_
52-22	9429-9434	after	_
52-23	9435-9445	Bonferroni	_
52-24	9446-9456	correction	_
52-25	9457-9458	(	_
52-26	9459-9468	corrected	_
52-27	9469-9470	p	_
52-28	9471-9472	>	_
52-29	9473-9477	0.95	_
52-30	9478-9479	)	_
52-31	9480-9481	.	_

Text=In addition, none of the differences between groups for the maximal head motion value was statistically significant after Bonferroni correction (corrected p> 0.35).
53-1	9482-9484	In	_
53-2	9485-9493	addition	_
53-3	9494-9495	,	_
53-4	9496-9500	none	_
53-5	9501-9503	of	_
53-6	9504-9507	the	_
53-7	9508-9519	differences	_
53-8	9520-9527	between	_
53-9	9528-9534	groups	_
53-10	9535-9538	for	_
53-11	9539-9542	the	_
53-12	9543-9550	maximal	_
53-13	9551-9555	head	_
53-14	9556-9562	motion	_
53-15	9563-9568	value	_
53-16	9569-9572	was	_
53-17	9573-9586	statistically	_
53-18	9587-9598	significant	_
53-19	9599-9604	after	_
53-20	9605-9615	Bonferroni	_
53-21	9616-9626	correction	_
53-22	9627-9628	(	_
53-23	9629-9638	corrected	_
53-24	9639-9640	p	_
53-25	9641-9642	>	_
53-26	9643-9647	0.35	_
53-27	9648-9649	)	_
53-28	9650-9651	.	_

Text=Following, an additional step of pre- processing was performed on the minimally-processed fMRI data: spatial smoothing with a 4-mm Gaussian kernel, using Statistical Para- metric Mapping 12 (SPM12) software (http: //www.fil.ion.ucl.ac.uk/spm/).
54-1	9652-9661	Following	_
54-2	9662-9663	,	_
54-3	9664-9666	an	_
54-4	9667-9677	additional	_
54-5	9678-9682	step	_
54-6	9683-9685	of	_
54-7	9686-9690	pre-	_
54-8	9691-9701	processing	_
54-9	9702-9705	was	_
54-10	9706-9715	performed	_
54-11	9716-9718	on	_
54-12	9719-9722	the	_
54-13	9723-9742	minimally-processed	_
54-14	9743-9747	fMRI	_
54-15	9748-9752	data	_
54-16	9753-9754	:	_
54-17	9755-9762	spatial	_
54-18	9763-9772	smoothing	_
54-19	9773-9777	with	_
54-20	9778-9779	a	_
54-21	9780-9784	4-mm	_
54-22	9785-9793	Gaussian	_
54-23	9794-9800	kernel	_
54-24	9801-9802	,	_
54-25	9803-9808	using	_
54-26	9809-9820	Statistical	_
54-27	9821-9826	Para-	_
54-28	9827-9833	metric	_
54-29	9834-9841	Mapping	_
54-30	9842-9844	12	_
54-31	9845-9846	(	_
54-32	9847-9852	SPM12	_
54-33	9853-9854	)	_
54-34	9855-9863	software	_
54-35	9864-9865	(	_
54-36	9866-9870	http	_
54-37	9871-9872	:	_
54-38	9873-9901	//www.fil.ion.ucl.ac.uk/spm/	_
54-39	9902-9903	)	_
54-40	9904-9905	.	_

Text=SPM univariate analysis of contrast activation The nodes of DCM were selected based on brain activation elicited by the working memory task, as revealed by SPM univariate analysis of contrast activation.
55-1	9906-9909	SPM	_
55-2	9910-9920	univariate	_
55-3	9921-9929	analysis	_
55-4	9930-9932	of	_
55-5	9933-9941	contrast	_
55-6	9942-9952	activation	_
55-7	9953-9956	The	_
55-8	9957-9962	nodes	_
55-9	9963-9965	of	_
55-10	9966-9969	DCM	_
55-11	9970-9974	were	_
55-12	9975-9983	selected	_
55-13	9984-9989	based	_
55-14	9990-9992	on	_
55-15	9993-9998	brain	_
55-16	9999-10009	activation	_
55-17	10010-10018	elicited	_
55-18	10019-10021	by	_
55-19	10022-10025	the	_
55-20	10026-10033	working	_
55-21	10034-10040	memory	_
55-22	10041-10045	task	_
55-23	10046-10047	,	_
55-24	10048-10050	as	_
55-25	10051-10059	revealed	_
55-26	10060-10062	by	_
55-27	10063-10066	SPM	_
55-28	10067-10077	univariate	_
55-29	10078-10086	analysis	_
55-30	10087-10089	of	_
55-31	10090-10098	contrast	_
55-32	10099-10109	activation	_
55-33	10110-10111	.	_

Text=In the first-level univariate statistical analysis, the two preprocessed fMRI runs were included in the model as two sessions.
56-1	10112-10114	In	_
56-2	10115-10118	the	_
56-3	10119-10130	first-level	_
56-4	10131-10141	univariate	_
56-5	10142-10153	statistical	_
56-6	10154-10162	analysis	_
56-7	10163-10164	,	_
56-8	10165-10168	the	_
56-9	10169-10172	two	_
56-10	10173-10185	preprocessed	_
56-11	10186-10190	fMRI	_
56-12	10191-10195	runs	_
56-13	10196-10200	were	_
56-14	10201-10209	included	_
56-15	10210-10212	in	_
56-16	10213-10216	the	_
56-17	10217-10222	model	_
56-18	10223-10225	as	_
56-19	10226-10229	two	_
56-20	10230-10238	sessions	_
56-21	10239-10240	.	_

Text=The 2-back and 0-back blocks were modeled by boxcar functions convolved with the SPM12 canonical hemodynamic response function.
57-1	10241-10244	The	_
57-2	10245-10251	2-back	_
57-3	10252-10255	and	_
57-4	10256-10262	0-back	_
57-5	10263-10269	blocks	_
57-6	10270-10274	were	_
57-7	10275-10282	modeled	_
57-8	10283-10285	by	_
57-9	10286-10292	boxcar	_
57-10	10293-10302	functions	_
57-11	10303-10312	convolved	_
57-12	10313-10317	with	_
57-13	10318-10321	the	_
57-14	10322-10327	SPM12	_
57-15	10328-10337	canonical	_
57-16	10338-10349	hemodynamic	_
57-17	10350-10358	response	_
57-18	10359-10367	function	_
57-19	10368-10369	.	_

Text=The parameters for each task condition were estimated using the General Linear Model without global normalization.
58-1	10370-10373	The	_
58-2	10374-10384	parameters	_
58-3	10385-10388	for	_
58-4	10389-10393	each	_
58-5	10394-10398	task	_
58-6	10399-10408	condition	_
58-7	10409-10413	were	_
58-8	10414-10423	estimated	_
58-9	10424-10429	using	_
58-10	10430-10433	the	_
58-11	10434-10441	General	_
58-12	10442-10448	Linear	_
58-13	10449-10454	Model	_
58-14	10455-10462	without	_
58-15	10463-10469	global	_
58-16	10470-10483	normalization	_
58-17	10484-10485	.	_

Text=Following, the fMRI data was high-pass filtered with a cut-off period of 200 s. Activation was defined as the contrast of 2-back – (minus) 0-back parameter estimate.
59-1	10486-10495	Following	_
59-2	10496-10497	,	_
59-3	10498-10501	the	_
59-4	10502-10506	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
59-5	10507-10511	data	_
59-6	10512-10515	was	_
59-7	10516-10525	high-pass	_
59-8	10526-10534	filtered	_
59-9	10535-10539	with	_
59-10	10540-10541	a	_
59-11	10542-10549	cut-off	_
59-12	10550-10556	period	_
59-13	10557-10559	of	_
59-14	10560-10563	200	_
59-15	10564-10566	s.	_
59-16	10567-10577	Activation	_
59-17	10578-10581	was	_
59-18	10582-10589	defined	_
59-19	10590-10592	as	_
59-20	10593-10596	the	_
59-21	10597-10605	contrast	_
59-22	10606-10608	of	_
59-23	10609-10615	2-back	_
59-24	10616-10617	–	_
59-25	10618-10619	(	_
59-26	10620-10625	minus	_
59-27	10626-10627	)	_
59-28	10628-10634	0-back	_
59-29	10635-10644	parameter	_
59-30	10645-10653	estimate	_
59-31	10654-10655	.	_

Text=In order to determine between-group differences in regional activation, an SPM12 second-level two-sample t-test was conducted voxel- wise for the 2-back–0-back contrast image.
60-1	10656-10658	In	_
60-2	10659-10664	order	_
60-3	10665-10667	to	_
60-4	10668-10677	determine	_
60-5	10678-10691	between-group	_
60-6	10692-10703	differences	_
60-7	10704-10706	in	_
60-8	10707-10715	regional	_
60-9	10716-10726	activation	_
60-10	10727-10728	,	_
60-11	10729-10731	an	_
60-12	10732-10737	SPM12	_
60-13	10738-10750	second-level	_
60-14	10751-10761	two-sample	_
60-15	10762-10768	t-test	_
60-16	10769-10772	was	_
60-17	10773-10782	conducted	_
60-18	10783-10789	voxel-	_
60-19	10790-10794	wise	_
60-20	10795-10798	for	_
60-21	10799-10802	the	_
60-22	10803-10816	2-back–0-back	_
60-23	10817-10825	contrast	_
60-24	10826-10831	image	_
60-25	10832-10833	.	_

Text=Statistical significance was defined as family-wise error corrected cluster probability (p) <(less than) 0.05 (two-tail).
61-1	10834-10845	Statistical	_
61-2	10846-10858	significance	_
61-3	10859-10862	was	_
61-4	10863-10870	defined	_
61-5	10871-10873	as	_
61-6	10874-10885	family-wise	_
61-7	10886-10891	error	_
61-8	10892-10901	corrected	_
61-9	10902-10909	cluster	_
61-10	10910-10921	probability	_
61-11	10922-10923	(	_
61-12	10924-10925	p	_
61-13	10926-10927	)	_
61-14	10928-10929	<	_
61-15	10930-10931	(	_
61-16	10932-10936	less	_
61-17	10937-10941	than	_
61-18	10942-10943	)	_
61-19	10944-10948	0.05	_
61-20	10949-10950	(	_
61-21	10951-10959	two-tail	_
61-22	10960-10961	)	_
61-23	10962-10963	.	_

Text=An SPM12 second-level one-sample t-test was conducted to determine the DCM nodes, which were selected based on the regions that activated across both groups combined.
62-1	10964-10966	An	_
62-2	10967-10972	SPM12	_
62-3	10973-10985	second-level	_
62-4	10986-10996	one-sample	_
62-5	10997-11003	t-test	_
62-6	11004-11007	was	_
62-7	11008-11017	conducted	_
62-8	11018-11020	to	_
62-9	11021-11030	determine	_
62-10	11031-11034	the	_
62-11	11035-11038	DCM	_
62-12	11039-11044	nodes	_
62-13	11045-11046	,	_
62-14	11047-11052	which	_
62-15	11053-11057	were	_
62-16	11058-11066	selected	_
62-17	11067-11072	based	_
62-18	11073-11075	on	_
62-19	11076-11079	the	_
62-20	11080-11087	regions	_
62-21	11088-11092	that	_
62-22	11093-11102	activated	_
62-23	11103-11109	across	_
62-24	11110-11114	both	_
62-25	11115-11121	groups	_
62-26	11122-11130	combined	_
62-27	11131-11132	.	_

Text=Uncorrected cluster p <0.05 (two-tail), which is commonly accepted for DCM node selection, was used as the activation threshold to define nodes for DCM analysis.
63-1	11133-11144	Uncorrected	_
63-2	11145-11152	cluster	_
63-3	11153-11154	p	_
63-4	11155-11156	<	_
63-5	11157-11161	0.05	_
63-6	11162-11163	(	_
63-7	11164-11172	two-tail	_
63-8	11173-11174	)	_
63-9	11175-11176	,	_
63-10	11177-11182	which	_
63-11	11183-11185	is	_
63-12	11186-11194	commonly	_
63-13	11195-11203	accepted	_
63-14	11204-11207	for	_
63-15	11208-11211	DCM	_
63-16	11212-11216	node	_
63-17	11217-11226	selection	_
63-18	11227-11228	,	_
63-19	11229-11232	was	_
63-20	11233-11237	used	_
63-21	11238-11240	as	_
63-22	11241-11244	the	_
63-23	11245-11255	activation	_
63-24	11256-11265	threshold	_
63-25	11266-11268	to	_
63-26	11269-11275	define	_
63-27	11276-11281	nodes	_
63-28	11282-11285	for	_
63-29	11286-11289	DCM	_
63-30	11290-11298	analysis	_
63-31	11299-11300	.	_

Text=For all second-level analyses, the cluster-defining threshold was t = 2.4.
64-1	11301-11304	For	_
64-2	11305-11308	all	_
64-3	11309-11321	second-level	_
64-4	11322-11330	analyses	_
64-5	11331-11332	,	_
64-6	11333-11336	the	_
64-7	11337-11353	cluster-defining	_
64-8	11354-11363	threshold	_
64-9	11364-11367	was	_
64-10	11368-11369	t	_
64-11	11370-11371	=	_
64-12	11372-11375	2.4	_
64-13	11376-11377	.	_

Text=Anatomical labels for regions of activation were determined using the Anatomical Automatic Labeling2 (AAL2) toolbox.
65-1	11378-11388	Anatomical	_
65-2	11389-11395	labels	_
65-3	11396-11399	for	_
65-4	11400-11407	regions	_
65-5	11408-11410	of	_
65-6	11411-11421	activation	_
65-7	11422-11426	were	_
65-8	11427-11437	determined	_
65-9	11438-11443	using	_
65-10	11444-11447	the	_
65-11	11448-11458	Anatomical	_
65-12	11459-11468	Automatic	_
65-13	11469-11478	Labeling2	_
65-14	11479-11480	(	_
65-15	11481-11485	AAL2	_
65-16	11486-11487	)	_
65-17	11488-11495	toolbox	_
65-18	11496-11497	.	_

Text=Dynamic causal modeling FMRI-based DCM is a biophysical model of how the underlying neuronal connectivity generates the observed fMRI signal.
66-1	11498-11505	Dynamic	_
66-2	11506-11512	causal	_
66-3	11513-11521	modeling	_
66-4	11522-11532	FMRI-based	_
66-5	11533-11536	DCM	_
66-6	11537-11539	is	_
66-7	11540-11541	a	_
66-8	11542-11553	biophysical	_
66-9	11554-11559	model	_
66-10	11560-11562	of	_
66-11	11563-11566	how	_
66-12	11567-11570	the	_
66-13	11571-11581	underlying	_
66-14	11582-11590	neuronal	_
66-15	11591-11603	connectivity	_
66-16	11604-11613	generates	_
66-17	11614-11617	the	_
66-18	11618-11626	observed	_
66-19	11627-11631	fMRI	_
66-20	11632-11638	signal	_
66-21	11639-11640	.	_

Text=DCM has been described elsewhere.
67-1	11641-11644	DCM	_
67-2	11645-11648	has	_
67-3	11649-11653	been	_
67-4	11654-11663	described	_
67-5	11664-11673	elsewhere	_
67-6	11674-11675	.	_

Text=In brief, DCM is a system of bilinear differential state equations with coefficients (in units of Hz).
68-1	11676-11678	In	_
68-2	11679-11684	brief	_
68-3	11685-11686	,	_
68-4	11687-11690	DCM	_
68-5	11691-11693	is	_
68-6	11694-11695	a	_
68-7	11696-11702	system	_
68-8	11703-11705	of	_
68-9	11706-11714	bilinear	_
68-10	11715-11727	differential	_
68-11	11728-11733	state	_
68-12	11734-11743	equations	_
68-13	11744-11748	with	_
68-14	11749-11761	coefficients	_
68-15	11762-11763	(	_
68-16	11764-11766	in	_
68-17	11767-11772	units	_
68-18	11773-11775	of	_
68-19	11776-11778	Hz	_
68-20	11779-11780	)	_
68-21	11781-11782	.	_

Text=A node in the model that receives driving inputs is the brain region which first experiences a change in neuronal activity.
69-1	11783-11784	A	_
69-2	11785-11789	node	_
69-3	11790-11792	in	_
69-4	11793-11796	the	_
69-5	11797-11802	model	_
69-6	11803-11807	that	_
69-7	11808-11816	receives	_
69-8	11817-11824	driving	_
69-9	11825-11831	inputs	_
69-10	11832-11834	is	_
69-11	11835-11838	the	_
69-12	11839-11844	brain	_
69-13	11845-11851	region	_
69-14	11852-11857	which	_
69-15	11858-11863	first	_
69-16	11864-11875	experiences	_
69-17	11876-11877	a	_
69-18	11878-11884	change	_
69-19	11885-11887	in	_
69-20	11888-11896	neuronal	_
69-21	11897-11905	activity	_
69-22	11906-11907	.	_

Text=This node then influences other nodes.
70-1	11908-11912	This	_
70-2	11913-11917	node	_
70-3	11918-11922	then	_
70-4	11923-11933	influences	_
70-5	11934-11939	other	_
70-6	11940-11945	nodes	_
70-7	11946-11947	.	_

Text=The endogenous connectivity measures the EC strengths between nodes, regardless of the moment-to-moment switching on and off of inputs.
71-1	11948-11951	The	_
71-2	11952-11962	endogenous	_
71-3	11963-11975	connectivity	_
71-4	11976-11984	measures	_
71-5	11985-11988	the	_
71-6	11989-11991	EC	_
71-7	11992-12001	strengths	_
71-8	12002-12009	between	_
71-9	12010-12015	nodes	_
71-10	12016-12017	,	_
71-11	12018-12028	regardless	_
71-12	12029-12031	of	_
71-13	12032-12035	the	_
71-14	12036-12052	moment-to-moment	_
71-15	12053-12062	switching	_
71-16	12063-12065	on	_
71-17	12066-12069	and	_
71-18	12070-12073	off	_
71-19	12074-12076	of	_
71-20	12077-12083	inputs	_
71-21	12084-12085	.	_

Text=In other words, endogenous connectivity is the overall default directionality and strength of connectivity irrespective of momentary task condition.
72-1	12086-12088	In	_
72-2	12089-12094	other	_
72-3	12095-12100	words	_
72-4	12101-12102	,	_
72-5	12103-12113	endogenous	_
72-6	12114-12126	connectivity	_
72-7	12127-12129	is	_
72-8	12130-12133	the	_
72-9	12134-12141	overall	_
72-10	12142-12149	default	_
72-11	12150-12164	directionality	_
72-12	12165-12168	and	_
72-13	12169-12177	strength	_
72-14	12178-12180	of	_
72-15	12181-12193	connectivity	_
72-16	12194-12206	irrespective	_
72-17	12207-12209	of	_
72-18	12210-12219	momentary	_
72-19	12220-12224	task	_
72-20	12225-12234	condition	_
72-21	12235-12236	.	_

Text=Experimental conditions can modulate the endogenous connectivities.
73-1	12237-12249	Experimental	_
73-2	12250-12260	conditions	_
73-3	12261-12264	can	_
73-4	12265-12273	modulate	_
73-5	12274-12277	the	_
73-6	12278-12288	endogenous	_
73-7	12289-12303	connectivities	_
73-8	12304-12305	.	_

Text=Their modulation effects quantify increased or decreased connectivity strength compared to the endogenous connectivity.
74-1	12306-12311	Their	_
74-2	12312-12322	modulation	_
74-3	12323-12330	effects	_
74-4	12331-12339	quantify	_
74-5	12340-12349	increased	_
74-6	12350-12352	or	_
74-7	12353-12362	decreased	_
74-8	12363-12375	connectivity	_
74-9	12376-12384	strength	_
74-10	12385-12393	compared	_
74-11	12394-12396	to	_
74-12	12397-12400	the	_
74-13	12401-12411	endogenous	_
74-14	12412-12424	connectivity	_
74-15	12425-12426	.	_

Text=Following, two new experimental conditions called “ All-back ” and “ 2-back – (minus) 0-back ” were created using appropriate parametric regressors as described in.
75-1	12427-12436	Following	_
75-2	12437-12438	,	_
75-3	12439-12442	two	_
75-4	12443-12446	new	_
75-5	12447-12459	experimental	_
75-6	12460-12470	conditions	_
75-7	12471-12477	called	_
75-8	12478-12479	“	_
75-9	12480-12488	All-back	_
75-10	12489-12490	”	_
75-11	12491-12494	and	_
75-12	12495-12496	“	_
75-13	12497-12503	2-back	_
75-14	12504-12505	–	_
75-15	12506-12507	(	_
75-16	12508-12513	minus	_
75-17	12514-12515	)	_
75-18	12516-12522	0-back	_
75-19	12523-12524	”	_
75-20	12525-12529	were	_
75-21	12530-12537	created	_
75-22	12538-12543	using	_
75-23	12544-12555	appropriate	_
75-24	12556-12566	parametric	_
75-25	12567-12577	regressors	_
75-26	12578-12580	as	_
75-27	12581-12590	described	_
75-28	12591-12593	in	_
75-29	12594-12595	.	_

Text=The “ All-back ” condition, which reflects the combined effect of the 2-back and 0-back stimuli, was used as a single input to the DCM.
76-1	12596-12599	The	_
76-2	12600-12601	“	_
76-3	12602-12610	All-back	_
76-4	12611-12612	”	_
76-5	12613-12622	condition	_
76-6	12623-12624	,	_
76-7	12625-12630	which	_
76-8	12631-12639	reflects	_
76-9	12640-12643	the	_
76-10	12644-12652	combined	_
76-11	12653-12659	effect	_
76-12	12660-12662	of	_
76-13	12663-12666	the	_
76-14	12667-12673	2-back	_
76-15	12674-12677	and	_
76-16	12678-12684	0-back	_
76-17	12685-12692	stimuli	_
76-18	12693-12694	,	_
76-19	12695-12698	was	_
76-20	12699-12703	used	_
76-21	12704-12706	as	_
76-22	12707-12708	a	_
76-23	12709-12715	single	_
76-24	12716-12721	input	_
76-25	12722-12724	to	_
76-26	12725-12728	the	_
76-27	12729-12732	DCM	_
76-28	12733-12734	.	_

Text=The 2-back–0-back condition, which reflects the special effect of 2-back over 0-back (i.e., increased WM demand), was used as a putative modulator of EC.
77-1	12735-12738	The	_
77-2	12739-12752	2-back–0-back	_
77-3	12753-12762	condition	_
77-4	12763-12764	,	_
77-5	12765-12770	which	_
77-6	12771-12779	reflects	_
77-7	12780-12783	the	_
77-8	12784-12791	special	_
77-9	12792-12798	effect	_
77-10	12799-12801	of	_
77-11	12802-12808	2-back	_
77-12	12809-12813	over	_
77-13	12814-12820	0-back	_
77-14	12821-12822	(	_
77-15	12823-12827	i.e.	_
77-16	12828-12829	,	_
77-17	12830-12839	increased	_
77-18	12840-12842	WM	_
77-19	12843-12849	demand	_
77-20	12850-12851	)	_
77-21	12852-12853	,	_
77-22	12854-12857	was	_
77-23	12858-12862	used	_
77-24	12863-12865	as	_
77-25	12866-12867	a	_
77-26	12868-12876	putative	_
77-27	12877-12886	modulator	_
77-28	12887-12889	of	_
77-29	12890-12892	EC	_
77-30	12893-12894	.	_

Text=In this study, the change in EC corresponding to the 2-back – 0-back modulator is termed as modulatory change.
78-1	12895-12897	In	_
78-2	12898-12902	this	_
78-3	12903-12908	study	_
78-4	12909-12910	,	_
78-5	12911-12914	the	_
78-6	12915-12921	change	_
78-7	12922-12924	in	_
78-8	12925-12927	EC	_
78-9	12928-12941	corresponding	_
78-10	12942-12944	to	_
78-11	12945-12948	the	_
78-12	12949-12955	2-back	_
78-13	12956-12957	–	_
78-14	12958-12964	0-back	_
78-15	12965-12974	modulator	_
78-16	12975-12977	is	_
78-17	12978-12984	termed	_
78-18	12985-12987	as	_
78-19	12988-12998	modulatory	_
78-20	12999-13005	change	_
78-21	13006-13007	.	_

Text=DCM nodes Following the procedures by), the DCM nodes (regions) were chosen based on simultaneously meeting all of the following criteria: (I) show activation (p <0.05 two-tail at uncorrected cluster level) in the SPM second-level analysis of the combined groups; (II) activate consistently during WM tasks in previous studies; (III) belong to visual and spatial cortico-striatal circuits; and (IV) belong to aberrant neurocircuits thought to underlie substance use disorders.
79-1	13008-13011	DCM	_
79-2	13012-13017	nodes	_
79-3	13018-13027	Following	_
79-4	13028-13031	the	_
79-5	13032-13042	procedures	_
79-6	13043-13045	by	_
79-7	13046-13047	)	_
79-8	13048-13049	,	_
79-9	13050-13053	the	_
79-10	13054-13057	DCM	_
79-11	13058-13063	nodes	_
79-12	13064-13065	(	_
79-13	13066-13073	regions	_
79-14	13074-13075	)	_
79-15	13076-13080	were	_
79-16	13081-13087	chosen	_
79-17	13088-13093	based	_
79-18	13094-13096	on	_
79-19	13097-13111	simultaneously	_
79-20	13112-13119	meeting	_
79-21	13120-13123	all	_
79-22	13124-13126	of	_
79-23	13127-13130	the	_
79-24	13131-13140	following	_
79-25	13141-13149	criteria	_
79-26	13150-13151	:	_
79-27	13152-13153	(	_
79-28	13154-13155	I	_
79-29	13156-13157	)	_
79-30	13158-13162	show	_
79-31	13163-13173	activation	_
79-32	13174-13175	(	_
79-33	13176-13177	p	_
79-34	13178-13179	<	_
79-35	13180-13184	0.05	_
79-36	13185-13193	two-tail	_
79-37	13194-13196	at	_
79-38	13197-13208	uncorrected	_
79-39	13209-13216	cluster	_
79-40	13217-13222	level	_
79-41	13223-13224	)	_
79-42	13225-13227	in	_
79-43	13228-13231	the	_
79-44	13232-13235	SPM	_
79-45	13236-13248	second-level	_
79-46	13249-13257	analysis	_
79-47	13258-13260	of	_
79-48	13261-13264	the	_
79-49	13265-13273	combined	_
79-50	13274-13280	groups	_
79-51	13281-13282	;	_
79-52	13283-13284	(	_
79-53	13285-13287	II	_
79-54	13288-13289	)	_
79-55	13290-13298	activate	_
79-56	13299-13311	consistently	_
79-57	13312-13318	during	_
79-58	13319-13321	WM	_
79-59	13322-13327	tasks	_
79-60	13328-13330	in	_
79-61	13331-13339	previous	_
79-62	13340-13347	studies	_
79-63	13348-13349	;	_
79-64	13350-13351	(	_
79-65	13352-13355	III	_
79-66	13356-13357	)	_
79-67	13358-13364	belong	_
79-68	13365-13367	to	_
79-69	13368-13374	visual	_
79-70	13375-13378	and	_
79-71	13379-13386	spatial	_
79-72	13387-13403	cortico-striatal	_
79-73	13404-13412	circuits	_
79-74	13413-13414	;	_
79-75	13415-13418	and	_
79-76	13419-13420	(	_
79-77	13421-13423	IV	_
79-78	13424-13425	)	_
79-79	13426-13432	belong	_
79-80	13433-13435	to	_
79-81	13436-13444	aberrant	_
79-82	13445-13458	neurocircuits	_
79-83	13459-13466	thought	_
79-84	13467-13469	to	_
79-85	13470-13478	underlie	_
79-86	13479-13488	substance	_
79-87	13489-13492	use	_
79-88	13493-13502	disorders	_
79-89	13503-13504	.	_

Text=Based on these criteria, the following six nodes were selected as DCM nodes: (1) L DLPFC; (2) R DLPFC; (3) L VLPFC (including inferior frontal gyrus pars opercularis, pars triangularis, and pars orbitalis); (4) R VLPFC; (5) L caudate; and (6) R caudate.
80-1	13505-13510	Based	_
80-2	13511-13513	on	_
80-3	13514-13519	these	_
80-4	13520-13528	criteria	_
80-5	13529-13530	,	_
80-6	13531-13534	the	_
80-7	13535-13544	following	_
80-8	13545-13548	six	_
80-9	13549-13554	nodes	_
80-10	13555-13559	were	_
80-11	13560-13568	selected	_
80-12	13569-13571	as	_
80-13	13572-13575	DCM	_
80-14	13576-13581	nodes	_
80-15	13582-13583	:	_
80-16	13584-13585	(	_
80-17	13586-13587	1	_
80-18	13588-13589	)	_
80-19	13590-13591	L	_
80-20	13592-13597	DLPFC	_
80-21	13598-13599	;	_
80-22	13600-13601	(	_
80-23	13602-13603	2	_
80-24	13604-13605	)	_
80-25	13606-13607	R	_
80-26	13608-13613	DLPFC	_
80-27	13614-13615	;	_
80-28	13616-13617	(	_
80-29	13618-13619	3	_
80-30	13620-13621	)	_
80-31	13622-13623	L	_
80-32	13624-13629	VLPFC	_
80-33	13630-13631	(	_
80-34	13632-13641	including	_
80-35	13642-13650	inferior	_
80-36	13651-13658	frontal	_
80-37	13659-13664	gyrus	_
80-38	13665-13669	pars	_
80-39	13670-13681	opercularis	_
80-40	13682-13683	,	_
80-41	13684-13688	pars	_
80-42	13689-13701	triangularis	_
80-43	13702-13703	,	_
80-44	13704-13707	and	_
80-45	13708-13712	pars	_
80-46	13713-13722	orbitalis	_
80-47	13723-13724	)	_
80-48	13725-13726	;	_
80-49	13727-13728	(	_
80-50	13729-13730	4	_
80-51	13731-13732	)	_
80-52	13733-13734	R	_
80-53	13735-13740	VLPFC	_
80-54	13741-13742	;	_
80-55	13743-13744	(	_
80-56	13745-13746	5	_
80-57	13747-13748	)	_
80-58	13749-13750	L	_
80-59	13751-13758	caudate	_
80-60	13759-13760	;	_
80-61	13761-13764	and	_
80-62	13765-13766	(	_
80-63	13767-13768	6	_
80-64	13769-13770	)	_
80-65	13771-13772	R	_
80-66	13773-13780	caudate	_
80-67	13781-13782	.	_

Text=The posterior parietal cortex was not included as a DCM node because this study chose to focus on fronto-striatal connectivity (see the Discussion section for expanded discussions).
81-1	13783-13786	The	_
81-2	13787-13796	posterior	_
81-3	13797-13805	parietal	_
81-4	13806-13812	cortex	_
81-5	13813-13816	was	_
81-6	13817-13820	not	_
81-7	13821-13829	included	_
81-8	13830-13832	as	_
81-9	13833-13834	a	_
81-10	13835-13838	DCM	_
81-11	13839-13843	node	_
81-12	13844-13851	because	_
81-13	13852-13856	this	_
81-14	13857-13862	study	_
81-15	13863-13868	chose	_
81-16	13869-13871	to	_
81-17	13872-13877	focus	_
81-18	13878-13880	on	_
81-19	13881-13896	fronto-striatal	_
81-20	13897-13909	connectivity	_
81-21	13910-13911	(	_
81-22	13912-13915	see	_
81-23	13916-13919	the	_
81-24	13920-13930	Discussion	_
81-25	13931-13938	section	_
81-26	13939-13942	for	_
81-27	13943-13951	expanded	_
81-28	13952-13963	discussions	_
81-29	13964-13965	)	_
81-30	13966-13967	.	_

Text=The regional activation corresponding to each node was obtained based on the set-theoretic intersection of the corresponding atlas-based binary mask and the activation clusters that were determined by the SPM second-level one-sample t-test.
82-1	13968-13971	The	_
82-2	13972-13980	regional	_
82-3	13981-13991	activation	_
82-4	13992-14005	corresponding	_
82-5	14006-14008	to	_
82-6	14009-14013	each	_
82-7	14014-14018	node	_
82-8	14019-14022	was	_
82-9	14023-14031	obtained	_
82-10	14032-14037	based	_
82-11	14038-14040	on	_
82-12	14041-14044	the	_
82-13	14045-14058	set-theoretic	_
82-14	14059-14071	intersection	_
82-15	14072-14074	of	_
82-16	14075-14078	the	_
82-17	14079-14092	corresponding	_
82-18	14093-14104	atlas-based	_
82-19	14105-14111	binary	_
82-20	14112-14116	mask	_
82-21	14117-14120	and	_
82-22	14121-14124	the	_
82-23	14125-14135	activation	_
82-24	14136-14144	clusters	_
82-25	14145-14149	that	_
82-26	14150-14154	were	_
82-27	14155-14165	determined	_
82-28	14166-14168	by	_
82-29	14169-14172	the	_
82-30	14173-14176	SPM	_
82-31	14177-14189	second-level	_
82-32	14190-14200	one-sample	_
82-33	14201-14207	t-test	_
82-34	14208-14209	.	_

Text=The atlas-derived binary masks for all brain regions were obtained from the AAL2 atlas.
83-1	14210-14213	The	_
83-2	14214-14227	atlas-derived	_
83-3	14228-14234	binary	_
83-4	14235-14240	masks	_
83-5	14241-14244	for	_
83-6	14245-14248	all	_
83-7	14249-14254	brain	_
83-8	14255-14262	regions	_
83-9	14263-14267	were	_
83-10	14268-14276	obtained	_
83-11	14277-14281	from	_
83-12	14282-14285	the	_
83-13	14286-14290	AAL2	_
83-14	14291-14296	atlas	_
83-15	14297-14298	.	_

Text=The binary mask for DLPFC was based on the binary mask of middle frontal gyrus (MFG), which was further constrained by the conservative bounding box (Brodmann Areas 46 and 9) defined in.
84-1	14299-14302	The	_
84-2	14303-14309	binary	_
84-3	14310-14314	mask	_
84-4	14315-14318	for	_
84-5	14319-14324	DLPFC	_
84-6	14325-14328	was	_
84-7	14329-14334	based	_
84-8	14335-14337	on	_
84-9	14338-14341	the	_
84-10	14342-14348	binary	_
84-11	14349-14353	mask	_
84-12	14354-14356	of	_
84-13	14357-14363	middle	_
84-14	14364-14371	frontal	_
84-15	14372-14377	gyrus	_
84-16	14378-14379	(	_
84-17	14380-14383	MFG	_
84-18	14384-14385	)	_
84-19	14386-14387	,	_
84-20	14388-14393	which	_
84-21	14394-14397	was	_
84-22	14398-14405	further	_
84-23	14406-14417	constrained	_
84-24	14418-14420	by	_
84-25	14421-14424	the	_
84-26	14425-14437	conservative	_
84-27	14438-14446	bounding	_
84-28	14447-14450	box	_
84-29	14451-14452	(	_
84-30	14453-14461	Brodmann	_
84-31	14462-14467	Areas	_
84-32	14468-14470	46	_
84-33	14471-14474	and	_
84-34	14475-14476	9	_
84-35	14477-14478	)	_
84-36	14479-14486	defined	_
84-37	14487-14489	in	_
84-38	14490-14491	.	_

Text=The regional fMRI activations were constrained by these binary masks, and the local maximum within each activation cluster was obtained.
85-1	14492-14495	The	_
85-2	14496-14504	regional	_
85-3	14505-14509	fMRI	_
85-4	14510-14521	activations	_
85-5	14522-14526	were	_
85-6	14527-14538	constrained	_
85-7	14539-14541	by	_
85-8	14542-14547	these	_
85-9	14548-14554	binary	_
85-10	14555-14560	masks	_
85-11	14561-14562	,	_
85-12	14563-14566	and	_
85-13	14567-14570	the	_
85-14	14571-14576	local	_
85-15	14577-14584	maximum	_
85-16	14585-14591	within	_
85-17	14592-14596	each	_
85-18	14597-14607	activation	_
85-19	14608-14615	cluster	_
85-20	14616-14619	was	_
85-21	14620-14628	obtained	_
85-22	14629-14630	.	_

Text=The nodes of DCM were defined as spheres (see Fig.
86-1	14631-14634	The	_
86-2	14635-14640	nodes	_
86-3	14641-14643	of	_
86-4	14644-14647	DCM	_
86-5	14648-14652	were	_
86-6	14653-14660	defined	_
86-7	14661-14663	as	_
86-8	14664-14671	spheres	_
86-9	14672-14673	(	_
86-10	14674-14677	see	_
86-11	14678-14681	Fig	_
86-12	14682-14683	.	_

Text=1 for the location) centered at the local maximum within each regional activation.
87-1	14684-14685	1	_
87-2	14686-14689	for	_
87-3	14690-14693	the	_
87-4	14694-14702	location	_
87-5	14703-14704	)	_
87-6	14705-14713	centered	_
87-7	14714-14716	at	_
87-8	14717-14720	the	_
87-9	14721-14726	local	_
87-10	14727-14734	maximum	_
87-11	14735-14741	within	_
87-12	14742-14746	each	_
87-13	14747-14755	regional	_
87-14	14756-14766	activation	_
87-15	14767-14768	.	_

Text=The radius for prefrontal nodes was 5 mm, and the radius for the caudate nodes was 3 mm.
88-1	14769-14772	The	_
88-2	14773-14779	radius	_
88-3	14780-14783	for	_
88-4	14784-14794	prefrontal	_
88-5	14795-14800	nodes	_
88-6	14801-14804	was	_
88-7	14805-14806	5	_
88-8	14807-14809	mm	_
88-9	14810-14811	,	_
88-10	14812-14815	and	_
88-11	14816-14819	the	_
88-12	14820-14826	radius	_
88-13	14827-14830	for	_
88-14	14831-14834	the	_
88-15	14835-14842	caudate	_
88-16	14843-14848	nodes	_
88-17	14849-14852	was	_
88-18	14853-14854	3	_
88-19	14855-14857	mm	_
88-20	14858-14859	.	_

Text=Smaller spheres were used as the caudate nodes because the regional activations in these regions were relatively smaller.
89-1	14860-14867	Smaller	_
89-2	14868-14875	spheres	_
89-3	14876-14880	were	_
89-4	14881-14885	used	_
89-5	14886-14888	as	_
89-6	14889-14892	the	_
89-7	14893-14900	caudate	_
89-8	14901-14906	nodes	_
89-9	14907-14914	because	_
89-10	14915-14918	the	_
89-11	14919-14927	regional	_
89-12	14928-14939	activations	_
89-13	14940-14942	in	_
89-14	14943-14948	these	_
89-15	14949-14956	regions	_
89-16	14957-14961	were	_
89-17	14962-14972	relatively	_
89-18	14973-14980	smaller	_
89-19	14981-14982	.	_

Text=The same nodes were used for each subject.
90-1	14983-14986	The	_
90-2	14987-14991	same	_
90-3	14992-14997	nodes	_
90-4	14998-15002	were	_
90-5	15003-15007	used	_
90-6	15008-15011	for	_
90-7	15012-15016	each	_
90-8	15017-15024	subject	_
90-9	15025-15026	.	_

Text=The fMRI time series of each node, i.e., the blood-oxygen-level de- pendent (BOLD) signal over time in that node, was extracted by using the principal-eigenvariate of that node.
91-1	15027-15030	The	_
91-2	15031-15035	fMRI	_
91-3	15036-15040	time	_
91-4	15041-15047	series	_
91-5	15048-15050	of	_
91-6	15051-15055	each	_
91-7	15056-15060	node	_
91-8	15061-15062	,	_
91-9	15063-15067	i.e.	_
91-10	15068-15069	,	_
91-11	15070-15073	the	_
91-12	15074-15092	blood-oxygen-level	_
91-13	15093-15096	de-	_
91-14	15097-15104	pendent	_
91-15	15105-15106	(	_
91-16	15107-15111	BOLD	_
91-17	15112-15113	)	_
91-18	15114-15120	signal	_
91-19	15121-15125	over	_
91-20	15126-15130	time	_
91-21	15131-15133	in	_
91-22	15134-15138	that	_
91-23	15139-15143	node	_
91-24	15144-15145	,	_
91-25	15146-15149	was	_
91-26	15150-15159	extracted	_
91-27	15160-15162	by	_
91-28	15163-15168	using	_
91-29	15169-15172	the	_
91-30	15173-15195	principal-eigenvariate	_
91-31	15196-15198	of	_
91-32	15199-15203	that	_
91-33	15204-15208	node	_
91-34	15209-15210	.	_

Text=Each time series was also adjusted by the F-contrast of the effects-of-interest.
92-1	15211-15215	Each	_
92-2	15216-15220	time	_
92-3	15221-15227	series	_
92-4	15228-15231	was	_
92-5	15232-15236	also	_
92-6	15237-15245	adjusted	_
92-7	15246-15248	by	_
92-8	15249-15252	the	_
92-9	15253-15263	F-contrast	_
92-10	15264-15266	of	_
92-11	15267-15270	the	_
92-12	15271-15290	effects-of-interest	_
92-13	15291-15292	.	_

Text=DCM parametric empirical Bayes (PEB) analysis The PEB approach, as implemented in SPM12 (Revision 6906), was used to evaluate group differences in the DCM parameters.
93-1	15293-15296	DCM	_
93-2	15297-15307	parametric	_
93-3	15308-15317	empirical	_
93-4	15318-15323	Bayes	_
93-5	15324-15325	(	_
93-6	15326-15329	PEB	_
93-7	15330-15331	)	_
93-8	15332-15340	analysis	_
93-9	15341-15344	The	_
93-10	15345-15348	PEB	_
93-11	15349-15357	approach	_
93-12	15358-15359	,	_
93-13	15360-15362	as	_
93-14	15363-15374	implemented	_
93-15	15375-15377	in	_
93-16	15378-15383	SPM12	_
93-17	15384-15385	(	_
93-18	15386-15394	Revision	_
93-19	15395-15399	6906	_
93-20	15400-15401	)	_
93-21	15402-15403	,	_
93-22	15404-15407	was	_
93-23	15408-15412	used	_
93-24	15413-15415	to	_
93-25	15416-15424	evaluate	_
93-26	15425-15430	group	_
93-27	15431-15442	differences	_
93-28	15443-15445	in	_
93-29	15446-15449	the	_
93-30	15450-15453	DCM	_
93-31	15454-15464	parameters	_
93-32	15465-15466	.	_

Text=PEB allows to empirically update priors for each subject during the DCM analysis.
94-1	15467-15470	PEB	_
94-2	15471-15477	allows	_
94-3	15478-15480	to	_
94-4	15481-15492	empirically	_
94-5	15493-15499	update	_
94-6	15500-15506	priors	_
94-7	15507-15510	for	_
94-8	15511-15515	each	_
94-9	15516-15523	subject	_
94-10	15524-15530	during	_
94-11	15531-15534	the	_
94-12	15535-15538	DCM	_
94-13	15539-15547	analysis	_
94-14	15548-15549	.	_

Text=The method of conducting PEB analysis can be found online (https: //en.wikibooks.org/wiki/User: Peterz/sandbox).
95-1	15550-15553	The	_
95-2	15554-15560	method	_
95-3	15561-15563	of	_
95-4	15564-15574	conducting	_
95-5	15575-15578	PEB	_
95-6	15579-15587	analysis	_
95-7	15588-15591	can	_
95-8	15592-15594	be	_
95-9	15595-15600	found	_
95-10	15601-15607	online	_
95-11	15608-15609	(	_
95-12	15610-15615	https	_
95-13	15616-15617	:	_
95-14	15618-15646	//en.wikibooks.org/wiki/User	_
95-15	15647-15648	:	_
95-16	15649-15663	Peterz/sandbox	_
95-17	15664-15665	)	_
95-18	15666-15667	.	_

Text=In brief, the analysis started from specifying an initial putative “ full ” model, which was related to the driving input (All-back stimuli) and the 2-back–0-back modulator defined above.
96-1	15668-15670	In	_
96-2	15671-15676	brief	_
96-3	15677-15678	,	_
96-4	15679-15682	the	_
96-5	15683-15691	analysis	_
96-6	15692-15699	started	_
96-7	15700-15704	from	_
96-8	15705-15715	specifying	_
96-9	15716-15718	an	_
96-10	15719-15726	initial	_
96-11	15727-15735	putative	_
96-12	15736-15737	“	_
96-13	15738-15742	full	_
96-14	15743-15744	”	_
96-15	15745-15750	model	_
96-16	15751-15752	,	_
96-17	15753-15758	which	_
96-18	15759-15762	was	_
96-19	15763-15770	related	_
96-20	15771-15773	to	_
96-21	15774-15777	the	_
96-22	15778-15785	driving	_
96-23	15786-15791	input	_
96-24	15792-15793	(	_
96-25	15794-15802	All-back	_
96-26	15803-15810	stimuli	_
96-27	15811-15812	)	_
96-28	15813-15816	and	_
96-29	15817-15820	the	_
96-30	15821-15834	2-back–0-back	_
96-31	15835-15844	modulator	_
96-32	15845-15852	defined	_
96-33	15853-15858	above	_
96-34	15859-15860	.	_

Text=The term “ full ” is used here in the sense that (1) the putative driving input entered all of the six nodes; (2) each node was putatively interconnected to all other nodes, and (3) the 2-back – 0-back modulator putatively modulated all of the 30 interconnectivities between nodes.
97-1	15861-15864	The	_
97-2	15865-15869	term	_
97-3	15870-15871	“	_
97-4	15872-15876	full	_
97-5	15877-15878	”	_
97-6	15879-15881	is	_
97-7	15882-15886	used	_
97-8	15887-15891	here	_
97-9	15892-15894	in	_
97-10	15895-15898	the	_
97-11	15899-15904	sense	_
97-12	15905-15909	that	_
97-13	15910-15911	(	_
97-14	15912-15913	1	_
97-15	15914-15915	)	_
97-16	15916-15919	the	_
97-17	15920-15928	putative	_
97-18	15929-15936	driving	_
97-19	15937-15942	input	_
97-20	15943-15950	entered	_
97-21	15951-15954	all	_
97-22	15955-15957	of	_
97-23	15958-15961	the	_
97-24	15962-15965	six	_
97-25	15966-15971	nodes	_
97-26	15972-15973	;	_
97-27	15974-15975	(	_
97-28	15976-15977	2	_
97-29	15978-15979	)	_
97-30	15980-15984	each	_
97-31	15985-15989	node	_
97-32	15990-15993	was	_
97-33	15994-16004	putatively	_
97-34	16005-16019	interconnected	_
97-35	16020-16022	to	_
97-36	16023-16026	all	_
97-37	16027-16032	other	_
97-38	16033-16038	nodes	_
97-39	16039-16040	,	_
97-40	16041-16044	and	_
97-41	16045-16046	(	_
97-42	16047-16048	3	_
97-43	16049-16050	)	_
97-44	16051-16054	the	_
97-45	16055-16061	2-back	_
97-46	16062-16063	–	_
97-47	16064-16070	0-back	_
97-48	16071-16080	modulator	_
97-49	16081-16091	putatively	_
97-50	16092-16101	modulated	_
97-51	16102-16105	all	_
97-52	16106-16108	of	_
97-53	16109-16112	the	_
97-54	16113-16115	30	_
97-55	16116-16135	interconnectivities	_
97-56	16136-16143	between	_
97-57	16144-16149	nodes	_
97-58	16150-16151	.	_

Text=Then, all full models (one per subject) were assembled into a cell array with one subject per row and one DCM per column.
98-1	16152-16156	Then	_
98-2	16157-16158	,	_
98-3	16159-16162	all	_
98-4	16163-16167	full	_
98-5	16168-16174	models	_
98-6	16175-16176	(	_
98-7	16177-16180	one	_
98-8	16181-16184	per	_
98-9	16185-16192	subject	_
98-10	16193-16194	)	_
98-11	16195-16199	were	_
98-12	16200-16209	assembled	_
98-13	16210-16214	into	_
98-14	16215-16216	a	_
98-15	16217-16221	cell	_
98-16	16222-16227	array	_
98-17	16228-16232	with	_
98-18	16233-16236	one	_
98-19	16237-16244	subject	_
98-20	16245-16248	per	_
98-21	16249-16252	row	_
98-22	16253-16256	and	_
98-23	16257-16260	one	_
98-24	16261-16264	DCM	_
98-25	16265-16268	per	_
98-26	16269-16275	column	_
98-27	16276-16277	.	_

Text=These models, as organized by the cell array, were estimated using the SPM12 code (spm_dcm_peb_fit.m), which facilitates drawing subjects out of local optima towards the group mean (https: //en.wikibooks.org/wiki/User: Peterz/sandbox).
99-1	16278-16283	These	_
99-2	16284-16290	models	_
99-3	16291-16292	,	_
99-4	16293-16295	as	_
99-5	16296-16305	organized	_
99-6	16306-16308	by	_
99-7	16309-16312	the	_
99-8	16313-16317	cell	_
99-9	16318-16323	array	_
99-10	16324-16325	,	_
99-11	16326-16330	were	_
99-12	16331-16340	estimated	_
99-13	16341-16346	using	_
99-14	16347-16350	the	_
99-15	16351-16356	SPM12	_
99-16	16357-16361	code	_
99-17	16362-16363	(	_
99-18	16364-16381	spm_dcm_peb_fit.m	_
99-19	16382-16383	)	_
99-20	16384-16385	,	_
99-21	16386-16391	which	_
99-22	16392-16403	facilitates	_
99-23	16404-16411	drawing	_
99-24	16412-16420	subjects	_
99-25	16421-16424	out	_
99-26	16425-16427	of	_
99-27	16428-16433	local	_
99-28	16434-16440	optima	_
99-29	16441-16448	towards	_
99-30	16449-16452	the	_
99-31	16453-16458	group	_
99-32	16459-16463	mean	_
99-33	16464-16465	(	_
99-34	16466-16471	https	_
99-35	16472-16473	:	_
99-36	16474-16502	//en.wikibooks.org/wiki/User	_
99-37	16503-16504	:	_
99-38	16505-16519	Peterz/sandbox	_
99-39	16520-16521	)	_
99-40	16522-16523	.	_

Text=Next, a second level (group) GLM and a design matrix (ones “ 1 ” for CUD subjects and negative ones “ −1 ” for controls) were specified, with alcohol and tobacco use as the covariates (Table 1).
100-1	16524-16528	Next	_
100-2	16529-16530	,	_
100-3	16531-16532	a	_
100-4	16533-16539	second	_
100-5	16540-16545	level	_
100-6	16546-16547	(	_
100-7	16548-16553	group	_
100-8	16554-16555	)	_
100-9	16556-16559	GLM	_
100-10	16560-16563	and	_
100-11	16564-16565	a	_
100-12	16566-16572	design	_
100-13	16573-16579	matrix	_
100-14	16580-16581	(	_
100-15	16582-16586	ones	_
100-16	16587-16588	“	_
100-17	16589-16590	1	_
100-18	16591-16592	”	_
100-19	16593-16596	for	_
100-20	16597-16600	CUD	_
100-21	16601-16609	subjects	_
100-22	16610-16613	and	_
100-23	16614-16622	negative	_
100-24	16623-16627	ones	_
100-25	16628-16629	“	_
100-26	16630-16632	−1	_
100-27	16633-16634	”	_
100-28	16635-16638	for	_
100-29	16639-16647	controls	_
100-30	16648-16649	)	_
100-31	16650-16654	were	_
100-32	16655-16664	specified	_
100-33	16665-16666	,	_
100-34	16667-16671	with	_
100-35	16672-16679	alcohol	_
100-36	16680-16683	and	_
100-37	16684-16691	tobacco	_
100-38	16692-16695	use	_
100-39	16696-16698	as	_
100-40	16699-16702	the	_
100-41	16703-16713	covariates	_
100-42	16714-16715	(	_
100-43	16716-16721	Table	_
100-44	16722-16723	1	_
100-45	16724-16725	)	_
100-46	16726-16727	.	_

Text=Based on the GLM, design matrix, and the estimated full models, the second level (group) PEB model was estimated using the SPM12 code (spm_dcm_peb.m).
101-1	16728-16733	Based	_
101-2	16734-16736	on	_
101-3	16737-16740	the	_
101-4	16741-16744	GLM	_
101-5	16745-16746	,	_
101-6	16747-16753	design	_
101-7	16754-16760	matrix	_
101-8	16761-16762	,	_
101-9	16763-16766	and	_
101-10	16767-16770	the	_
101-11	16771-16780	estimated	_
101-12	16781-16785	full	_
101-13	16786-16792	models	_
101-14	16793-16794	,	_
101-15	16795-16798	the	_
101-16	16799-16805	second	_
101-17	16806-16811	level	_
101-18	16812-16813	(	_
101-19	16814-16819	group	_
101-20	16820-16821	)	_
101-21	16822-16825	PEB	_
101-22	16826-16831	model	_
101-23	16832-16835	was	_
101-24	16836-16845	estimated	_
101-25	16846-16851	using	_
101-26	16852-16855	the	_
101-27	16856-16861	SPM12	_
101-28	16862-16866	code	_
101-29	16867-16868	(	_
101-30	16869-16882	spm_dcm_peb.m	_
101-31	16883-16884	)	_
101-32	16885-16886	.	_

Text=The estimated PEB model contains all parameters representing group effects on each DCM parameter.
102-1	16887-16890	The	_
102-2	16891-16900	estimated	_
102-3	16901-16904	PEB	_
102-4	16905-16910	model	_
102-5	16911-16919	contains	_
102-6	16920-16923	all	_
102-7	16924-16934	parameters	_
102-8	16935-16947	representing	_
102-9	16948-16953	group	_
102-10	16954-16961	effects	_
102-11	16962-16964	on	_
102-12	16965-16969	each	_
102-13	16970-16973	DCM	_
102-14	16974-16983	parameter	_
102-15	16984-16985	.	_

Text=After that, between-group effects were identified using the SPM12 code (spm_dcm_peb_bmc.m), which prunes away any para- meters from the PEB model that do not contribute to the model evidence.
103-1	16986-16991	After	_
103-2	16992-16996	that	_
103-3	16997-16998	,	_
103-4	16999-17012	between-group	_
103-5	17013-17020	effects	_
103-6	17021-17025	were	_
103-7	17026-17036	identified	_
103-8	17037-17042	using	_
103-9	17043-17046	the	_
103-10	17047-17052	SPM12	_
103-11	17053-17057	code	_
103-12	17058-17059	(	_
103-13	17060-17077	spm_dcm_peb_bmc.m	_
103-14	17078-17079	)	_
103-15	17080-17081	,	_
103-16	17082-17087	which	_
103-17	17088-17094	prunes	_
103-18	17095-17099	away	_
103-19	17100-17103	any	_
103-20	17104-17109	para-	_
103-21	17110-17116	meters	_
103-22	17117-17121	from	_
103-23	17122-17125	the	_
103-24	17126-17129	PEB	_
103-25	17130-17135	model	_
103-26	17136-17140	that	_
103-27	17141-17143	do	_
103-28	17144-17147	not	_
103-29	17148-17158	contribute	_
103-30	17159-17161	to	_
103-31	17162-17165	the	_
103-32	17166-17171	model	_
103-33	17172-17180	evidence	_
103-34	17181-17182	.	_

Text=Statistical analysis Student ’ s t-test was used to evaluate group differences on continuous variables (e.g., age).
104-1	17183-17194	Statistical	_
104-2	17195-17203	analysis	_
104-3	17204-17211	Student	_
104-4	17212-17213	’	_
104-5	17214-17215	s	_
104-6	17216-17222	t-test	_
104-7	17223-17226	was	_
104-8	17227-17231	used	_
104-9	17232-17234	to	_
104-10	17235-17243	evaluate	_
104-11	17244-17249	group	_
104-12	17250-17261	differences	_
104-13	17262-17264	on	_
104-14	17265-17275	continuous	_
104-15	17276-17285	variables	_
104-16	17286-17287	(	_
104-17	17288-17292	e.g.	_
104-18	17293-17294	,	_
104-19	17295-17298	age	_
104-20	17299-17300	)	_
104-21	17301-17302	.	_

Text=Fisher ’ s exact test was used to evaluate group differences on categorical variables (e.g., sex).
105-1	17303-17309	Fisher	_
105-2	17310-17311	’	_
105-3	17312-17313	s	_
105-4	17314-17319	exact	_
105-5	17320-17324	test	_
105-6	17325-17328	was	_
105-7	17329-17333	used	_
105-8	17334-17336	to	_
105-9	17337-17345	evaluate	_
105-10	17346-17351	group	_
105-11	17352-17363	differences	_
105-12	17364-17366	on	_
105-13	17367-17378	categorical	_
105-14	17379-17388	variables	_
105-15	17389-17390	(	_
105-16	17391-17395	e.g.	_
105-17	17396-17397	,	_
105-18	17398-17401	sex	_
105-19	17402-17403	)	_
105-20	17404-17405	.	_

Text=An analysis of variance (ANOVA) was used to analyze behavioral performance, with group (CUD and Control) as the between-subjects factor, and working memory level (2-back and 0-back) as the within-subjects factor.
106-1	17406-17408	An	_
106-2	17409-17417	analysis	_
106-3	17418-17420	of	_
106-4	17421-17429	variance	_
106-5	17430-17431	(	_
106-6	17432-17437	ANOVA	_
106-7	17438-17439	)	_
106-8	17440-17443	was	_
106-9	17444-17448	used	_
106-10	17449-17451	to	_
106-11	17452-17459	analyze	_
106-12	17460-17470	behavioral	_
106-13	17471-17482	performance	_
106-14	17483-17484	,	_
106-15	17485-17489	with	_
106-16	17490-17495	group	_
106-17	17496-17497	(	_
106-18	17498-17501	CUD	_
106-19	17502-17505	and	_
106-20	17506-17513	Control	_
106-21	17514-17515	)	_
106-22	17516-17518	as	_
106-23	17519-17522	the	_
106-24	17523-17539	between-subjects	_
106-25	17540-17546	factor	_
106-26	17547-17548	,	_
106-27	17549-17552	and	_
106-28	17553-17560	working	_
106-29	17561-17567	memory	_
106-30	17568-17573	level	_
106-31	17574-17575	(	_
106-32	17576-17582	2-back	_
106-33	17583-17586	and	_
106-34	17587-17593	0-back	_
106-35	17594-17595	)	_
106-36	17596-17598	as	_
106-37	17599-17602	the	_
106-38	17603-17618	within-subjects	_
106-39	17619-17625	factor	_
106-40	17626-17627	.	_

Text=Spearman partial correlation (with alcohol use and tobacco use as covariates) was used for the correlation analysis.
107-1	17628-17636	Spearman	_
107-2	17637-17644	partial	_
107-3	17645-17656	correlation	_
107-4	17657-17658	(	_
107-5	17659-17663	with	_
107-6	17664-17671	alcohol	_
107-7	17672-17675	use	_
107-8	17676-17679	and	_
107-9	17680-17687	tobacco	_
107-10	17688-17691	use	_
107-11	17692-17694	as	_
107-12	17695-17705	covariates	_
107-13	17706-17707	)	_
107-14	17708-17711	was	_
107-15	17712-17716	used	_
107-16	17717-17720	for	_
107-17	17721-17724	the	_
107-18	17725-17736	correlation	_
107-19	17737-17745	analysis	_
107-20	17746-17747	.	_

